Legislator
Legislator > Sarah Keyeski
State Senator
Sarah Keyeski
(D) - Wisconsin
Wisconsin Senate District 14
In Office - Started: 01/06/2025
contact info
Capitol Office
P.O. Box 7882
State Capitol, 2 E. Main St.
Madison, WI 53707
State Capitol, 2 E. Main St.
Madison, WI 53707
Phone: 608-266-0751
| Bill | Bill Name | Summary | Progress |
|---|---|---|---|
| AB80 | Ratification of the Social Work Licensure Compact. (FE) | This bill ratifies and enters Wisconsin into the Social Work Licensure Compact, which provides for the ability of a social worker to become eligible to practice in other compact states. Significant provisions of the compact include the following: 1. The creation of a Social Work Licensure Compact Commission, which includes one member or administrator of the licensure authorities of each member state. The commission has various powers and duties granted in the compact, including establishing bylaws, promulgating binding rules for the compact, hiring officers, electing or appointing employees, and establishing and electing an executive committee. The commission may levy on and collect an annual assessment from each member state or impose fees on licensees of member states to cover the cost of the operations and activities of the commission and its staff. 2. The ability for a social worker who is licensed in a home state and satisfies certain other criteria to obtain a multistate license, which allows a social worker to practice social work in all other compact states (remote states) under a multistate authorization to practice. The compact specifies a number of requirements in order for an individual to obtain a social worker multistate license, including holding or being eligible for a social worker license in a home state, paying any required fees, and satisfying a number of criteria that are specific to the category of social work license the individual is seeking—bachelor[s, master[s, or clinical. A regulated social worker[s services in a remote state are subject to that member state[s regulatory authority. A remote state may take actions against a social worker[s multistate authorization to practice within that remote state, and if any adverse action is taken by a home state against a licensee[s multistate license, the social worker[s multistate authorization to practice in all other member states is deactivated until all encumbrances have been removed from the multistate license. 3. The ability of member states to issue subpoenas that are enforceable in other states. 4. The creation of a coordinated data system containing licensure and disciplinary action information on social workers. The compact requires all home state disciplinary orders that impose adverse actions against the license of a regulated social worker to include a statement that the regulated social worker[s multistate authorization to practice is deactivated in all member states until all conditions of the decision, order, or agreement are satisfied. A member state must submit a uniform data set to the data system on all individuals to whom the compact is applicable as required by the rules of the commission. 5. Provisions regarding resolutions of disputes among member states and between member and nonmember states, including a process for termination of a state[s membership in the compact if the state defaults on its obligations under the compact. Since the compact has already been enacted by the minimum number of states required for it to become active, the compact becomes effective in this state upon enactment of the bill. The compact provides that it may be amended upon enactment of an amendment by all member states. A state may withdraw from the compact by repealing the statute authorizing the compact, but the compact provides that a withdrawal does not take effect until 180 days after the effective date of that repeal. For further information see the state fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| AB257 | Advanced practice registered nurses, extending the time limit for emergency rule procedures, providing an exemption from emergency rule procedures, and granting rule-making authority. (FE) | NURSING PRACTICE AND LICENSURE This bill makes various changes to practice, licensure, and certification requirements for nurses, which are administered by the Board of Nursing. Licensure of advanced practice registered nurses Under current law, a person who wishes to practice professional nursing must be licensed by the Board of Nursing as a registered nurse (RN). This bill creates an additional system of licensure for advanced practice registered nurses (APRNs), to be administered by the board. Under the bill, in order to apply for an APRN license, a person must 1) hold, or concurrently apply for, an RN license; 2) have completed an accredited graduate-level or postgraduate-level education program preparing the person to practice as an APRN in one of four recognized roles and hold a current national certification approved by the board; 3) possess malpractice liability insurance as provided in the bill; 4) pay a fee determined by the Department of Safety and Professional Services; and 5) satisfy certain other criteria specified in the bill. The bill also allows a person who has not completed an accredited education program described above to receive an APRN license if the person 1) on January 1, 2026, is both licensed as an RN in Wisconsin and practicing in one of the four recognized roles and 2) satisfies additional practice or education criteria established by the board. The bill also, however, automatically grants licenses to certain RNs, as further described below. The four recognized roles, as defined in the bill, are 1) certified nurse-midwife; 2) certified registered nurse anesthetist; 3) clinical nurse specialist; and 4) nurse practitioner. The bill requires the board, upon granting a person an APRN license, to also grant the person one or more specialty designations corresponding to the recognized role or roles for which the person qualifies. Under the bill, all APRNs, except APRNs with a certified nurse-midwife specialty designation, must practice in collaboration with a physician or dentist. However, under the bill, an APRN may practice without being supervised by a physician or dentist if the board verifies that the APRN has completed 3,840 hours of professional nursing in a clinical setting and has completed 3,840 clinical hours of advanced practice registered nursing practice in their recognized role while working with a physician or dentist during those 3,840 hours of practice. APRNs may count additional hours practiced as an APRN in collaboration with a physician or dentist towards the 3,840 required hours of professional nursing. APRNs with a certified nurse-midwife specialty designation are instead required, if they offer to deliver babies outside of a hospital setting, to file and keep current with the board a proactive plan for involving a hospital or a physician who has admitting privileges at a hospital in the treatment of patients with higher acuity or emergency care needs, as further described below. Regardless of whether an APRN has qualified to practice independently, the bill provides that an APRN may provide treatment of pain syndromes through the use of invasive techniques only while working in a collaborative relationship with any physician who, through education, training, and experience, specializes in pain management. Alternatively, if an APRN has qualified to practice independently, the APRN may provide treatment of pain syndromes through the use of invasive techniques in a hospital or clinic associated with a hospital. Further, an APRN may provide treatment of pain syndromes through the use of invasive techniques if the APRN has qualified to practice independently and has privileges in a hospital to provide treatment of pain syndromes through the use of invasive techniques without a collaborative relationship with a physician. The holder of an APRN license may append the title XA.P.R.N.Y to his or her name, as well as a title corresponding to whichever specialty designations that the person possesses. The bill prohibits any person from using the title XA.P.R.N.,Y and from otherwise indicating that he or she is an APRN, unless the person is licensed by the board as an APRN. The bill also prohibits the use of titles and abbreviations corresponding to a recognized role unless the person has a specialty designation for that role. The bill further prohibits any person licensed by the board from using, assuming, or appending to his or her name any title that is not granted under the nursing statutes unless the person holds another credential that entitles the person to use, assume, or append to his or her name the title or the person is permitted to use, assume, or append to his or her name the title under any other law of the state. However, the bill provides that a person who is licensed by the board and holds a doctorate degree is not prohibited from using, assuming, or appending to his or her name the title XdoctorY or any other words, letters, or abbreviations that represent that the person holds that doctorate degree or the field in which the degree was received. If a person who is licensed by the board uses, assumes, or appends to his or her name the title Xdoctor,Y the bill requires that person to also use, assume, or append to his or her name words, letters, or abbreviations that represent the field in which the person received the doctorate degree. Further, the bill provides that a person who holds a bachelor[s degree or master[s degree is not prohibited from using, assuming, or appending to his or her name any words, letters, or abbreviations that represent that the person holds that degree or the field in which the degree was received. The bill allows an APRN to delegate a task or order to another clinically trained health care worker if the task or order is within the scope of the APRN[s practice, the APRN is competent to perform the task or issue the order, and the APRN has reasonable evidence that the health care worker is minimally competent to perform the task or issue the order under the circumstances. The bill requires an APRN to adhere to professional standards when managing situations that are beyond the APRN[s expertise. Under the bill, when an APRN renews his or her APRN license, the board must grant the person the renewal of both the person[s RN license and the person[s APRN license. The bill requires all APRNs to complete continuing education requirements each biennium in clinical pharmacology or therapeutics relevant to the APRN[s area of practice and to satisfy certain other requirements when renewing a license. Practice of nurse-midwifery This bill repeals licensure and practice requirements specific to nurse- midwives and the practice of nurse-midwifery, including specific requirements to practice with an obstetrician. Under the bill, Xcertified nurse-midwifeY is one of the four recognized roles for APRNs, and a person who is licensed as a nurse-midwife under current law is automatically granted an APRN license with a certified nurse- midwife specialty designation. The bill otherwise allows nurse-midwives to be licensed as APRNs if they satisfy the licensure requirements, except that the bill also requires that a person applying for a certified nurse-midwife specialty designation be certified by the American Midwifery Certification Board. The bill also requires an APRN with a specialty designation as a certified nurse-midwife to file with the Board of Nursing, and obtain the board[s approval of, a plan for ensuring appropriate care or care transitions in treating certain patients if the APRN offers to deliver babies outside of a hospital setting. Prescribing authority Under current law, a person licensed as an RN may apply to the Board of Nursing for a certificate to issue prescription orders if the person meets certain requirements established by the board. An RN holding a certificate is subject to various practice requirements and limitations established by the board and must possess malpractice liability insurance in an amount determined by the board. The bill eliminates certificates to issue prescription orders and generally authorizes APRNs to issue prescription orders. A person who is certified to issue prescription orders under current law is automatically granted an APRN license with his or her appropriate specialty designation. RNs who are practicing in a recognized role on January 1, 2026, but who do not hold a certificate to issue prescription orders on that date and who are granted an APRN license under the bill may not issue prescription orders. As under current law, an APRN issuing prescription orders is subject to various practice requirements and limitations established by the board. The bill repeals a provision concerning the ability of advanced practice nurses who are certified to issue prescription orders and who are required to work in collaboration with or under the supervision of a physician to obtain and practice under a federal waiver to dispense narcotic drugs to individuals for addiction treatment. Malpractice liability insurance The bill requires all APRNs to maintain malpractice liability insurance coverage evidenced by personal liability coverage in the amounts specified under current law for physicians and nurse anesthetists or coverage under a group liability policy providing individual coverage for the APRN in the amounts specified under current law for physicians and nurse anesthetists. Additionally, the bill requires APRNs who have qualified to practice independently and who practice outside a collaborative or employment relationship to participate in the Injured Patients and Families Compensation Fund. The Injured Patients and Families Compensation Fund provides excess medical malpractice coverage for health care providers who participate in the fund and meet all other participation requirements, which includes maintaining malpractice liability insurance in coverage amounts specified under current law. OTHER CHANGES The bill makes numerous other changes throughout the statutes relating to APRNs, including various terminology changes. For further information see the state fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| SB288 | Authorized lights for funeral procession vehicles. | Under current law, the lead vehicle, or all vehicles, in a funeral procession may be equipped with a flashing amber light to be used during the procession. This bill authorizes the use of a flashing purple light during a funeral procession. | In Committee |
| SJR60 | Proclaiming June 6, 2025, as Gun Violence Awareness Day in Wisconsin. | Relating to: proclaiming June 6, 2025, as Gun Violence Awareness Day in Wisconsin. | In Committee |
| SJR62 | Proclaiming January 1, 2025, to December 31, 2025, as Wisconsin State Park System 125th Anniversary. | Relating to: proclaiming January 1, 2025, to December 31, 2025, as Wisconsin State Park System 125th Anniversary. | In Committee |
| SB292 | Local regulation of pesticides to protect pollinators. | This bill allows a political subdivision to regulate pesticides for the purpose of protecting pollinators and pollinator habitats. Current law prohibits a political subdivision (a city, village, town, or county) from prohibiting the use of or otherwise regulating pesticides but provides numerous exemptions. For example, a political subdivision may enact an ordinance that regulates pesticides pursuant to a storm water management program or that relates to the storage, treatment, or disposal of solid waste that contains pesticides. The bill adds an additional exemption that allows a political subdivision to regulate pesticides in order to protect pollinators and pollinator habitats. XPollinatorY is defined in the bill as an insect that pollinates flowers. | In Committee |
| SB298 | Ban on the use of certain insecticides by the Department of Natural Resources. | This bill prohibits, with limited exceptions, the Department of Natural Resources from using any insecticide from the neonicotinoid class on land maintained by DNR. Under the bill, this prohibition does not apply to uses of this insecticide that are 1) pursuant to existing cooperative farming agreements or contracts or 2) for forest insect control on forested lands, state forest nurseries, or seed orchards or in designated zones of infestation. | In Committee |
| SB258 | Advanced practice registered nurses, extending the time limit for emergency rule procedures, providing an exemption from emergency rule procedures, and granting rule-making authority. (FE) | NURSING PRACTICE AND LICENSURE This bill makes various changes to practice, licensure, and certification requirements for nurses, which are administered by the Board of Nursing. Licensure of advanced practice registered nurses Under current law, a person who wishes to practice professional nursing must be licensed by the Board of Nursing as a registered nurse (RN). This bill creates an additional system of licensure for advanced practice registered nurses (APRNs), to be administered by the board. Under the bill, in order to apply for an APRN license, a person must 1) hold, or concurrently apply for, an RN license; 2) have completed an accredited graduate-level or postgraduate-level education program preparing the person to practice as an APRN in one of four recognized roles and hold a current national certification approved by the board; 3) possess malpractice liability insurance as provided in the bill; 4) pay a fee determined by the Department of Safety and Professional Services; and 5) satisfy certain other criteria specified in the bill. The bill also allows a person who has not completed an accredited education program described above to receive an APRN license if the person 1) on January 1, 2026, is both licensed as an RN in Wisconsin and practicing in one of the four recognized roles and 2) satisfies additional practice or education criteria established by the board. The bill also, however, automatically grants licenses to certain RNs, as further described below. The four recognized roles, as defined in the bill, are 1) certified nurse-midwife; 2) certified registered nurse anesthetist; 3) clinical nurse specialist; and 4) nurse practitioner. The bill requires the board, upon granting a person an APRN license, to also grant the person one or more specialty designations corresponding to the recognized role or roles for which the person qualifies. Under the bill, all APRNs, except APRNs with a certified nurse-midwife specialty designation, must practice in collaboration with a physician or dentist. However, under the bill, an APRN may practice without being supervised by a physician or dentist if the board verifies that the APRN has completed 3,840 hours of professional nursing in a clinical setting and has completed 3,840 clinical hours of advanced practice registered nursing practice in their recognized role while working with a physician or dentist during those 3,840 hours of practice. APRNs may count additional hours practiced as an APRN in collaboration with a physician or dentist towards the 3,840 required hours of professional nursing. APRNs with a LRB-1565/1 JPC:emw&wlj 2025 - 2026 Legislature SENATE BILL 258 certified nurse-midwife specialty designation are instead required, if they offer to deliver babies outside of a hospital setting, to file and keep current with the board a proactive plan for involving a hospital or a physician who has admitting privileges at a hospital in the treatment of patients with higher acuity or emergency care needs, as further described below. Regardless of whether an APRN has qualified to practice independently, the bill provides that an APRN may provide treatment of pain syndromes through the use of invasive techniques only while working in a collaborative relationship with any physician who, through education, training, and experience, specializes in pain management. Alternatively, if an APRN has qualified to practice independently, the APRN may provide treatment of pain syndromes through the use of invasive techniques in a hospital or clinic associated with a hospital. Further, an APRN may provide treatment of pain syndromes through the use of invasive techniques if the APRN has qualified to practice independently and has privileges in a hospital to provide treatment of pain syndromes through the use of invasive techniques without a collaborative relationship with a physician. The holder of an APRN license may append the title XA.P.R.N.Y to his or her name, as well as a title corresponding to whichever specialty designations that the person possesses. The bill prohibits any person from using the title XA.P.R.N.,Y and from otherwise indicating that he or she is an APRN, unless the person is licensed by the board as an APRN. The bill also prohibits the use of titles and abbreviations corresponding to a recognized role unless the person has a specialty designation for that role. The bill further prohibits any person licensed by the board from using, assuming, or appending to his or her name any title that is not granted under the nursing statutes unless the person holds another credential that entitles the person to use, assume, or append to his or her name the title or the person is permitted to use, assume, or append to his or her name the title under any other law of the state. However, the bill provides that a person who is licensed by the board and holds a doctorate degree is not prohibited from using, assuming, or appending to his or her name the title XdoctorY or any other words, letters, or abbreviations that represent that the person holds that doctorate degree or the field in which the degree was received. If a person who is licensed by the board uses, assumes, or appends to his or her name the title Xdoctor,Y the bill requires that person to also use, assume, or append to his or her name words, letters, or abbreviations that represent the field in which the person received the doctorate degree. Further, the bill provides that a person who holds a bachelor[s degree or master[s degree is not prohibited from using, assuming, or appending to his or her name any words, letters, or abbreviations that represent that the person holds that degree or the field in which the degree was received. The bill allows an APRN to delegate a task or order to another clinically trained health care worker if the task or order is within the scope of the APRN[s practice, the APRN is competent to perform the task or issue the order, and the APRN has reasonable evidence that the health care worker is minimally competent LRB-1565/1 JPC:emw&wlj 2025 - 2026 Legislature SENATE BILL 258 to perform the task or issue the order under the circumstances. The bill requires an APRN to adhere to professional standards when managing situations that are beyond the APRN[s expertise. Under the bill, when an APRN renews his or her APRN license, the board must grant the person the renewal of both the person[s RN license and the person[s APRN license. The bill requires all APRNs to complete continuing education requirements each biennium in clinical pharmacology or therapeutics relevant to the APRN[s area of practice and to satisfy certain other requirements when renewing a license. Practice of nurse-midwifery This bill repeals licensure and practice requirements specific to nurse- midwives and the practice of nurse-midwifery, including specific requirements to practice with an obstetrician. Under the bill, Xcertified nurse-midwifeY is one of the four recognized roles for APRNs, and a person who is licensed as a nurse-midwife under current law is automatically granted an APRN license with a certified nurse- midwife specialty designation. The bill otherwise allows nurse-midwives to be licensed as APRNs if they satisfy the licensure requirements, except that the bill also requires that a person applying for a certified nurse-midwife specialty designation be certified by the American Midwifery Certification Board. The bill also requires an APRN with a specialty designation as a certified nurse-midwife to file with the Board of Nursing, and obtain the board[s approval of, a plan for ensuring appropriate care or care transitions in treating certain patients if the APRN offers to deliver babies outside of a hospital setting. Prescribing authority Under current law, a person licensed as an RN may apply to the Board of Nursing for a certificate to issue prescription orders if the person meets certain requirements established by the board. An RN holding a certificate is subject to various practice requirements and limitations established by the board and must possess malpractice liability insurance in an amount determined by the board. The bill eliminates certificates to issue prescription orders and generally authorizes APRNs to issue prescription orders. A person who is certified to issue prescription orders under current law is automatically granted an APRN license with his or her appropriate specialty designation. RNs who are practicing in a recognized role on January 1, 2026, but who do not hold a certificate to issue prescription orders on that date and who are granted an APRN license under the bill may not issue prescription orders. As under current law, an APRN issuing prescription orders is subject to various practice requirements and limitations established by the board. The bill repeals a provision concerning the ability of advanced practice nurses who are certified to issue prescription orders and who are required to work in collaboration with or under the supervision of a physician to obtain and practice LRB-1565/1 JPC:emw&wlj 2025 - 2026 Legislature SENATE BILL 258 under a federal waiver to dispense narcotic drugs to individuals for addiction treatment. Malpractice liability insurance The bill requires all APRNs to maintain malpractice liability insurance coverage evidenced by personal liability coverage in the amounts specified under current law for physicians and nurse anesthetists or coverage under a group liability policy providing individual coverage for the APRN in the amounts specified under current law for physicians and nurse anesthetists. Additionally, the bill requires APRNs who have qualified to practice independently and who practice outside a collaborative or employment relationship to participate in the Injured Patients and Families Compensation Fund. The Injured Patients and Families Compensation Fund provides excess medical malpractice coverage for health care providers who participate in the fund and meet all other participation requirements, which includes maintaining malpractice liability insurance in coverage amounts specified under current law. OTHER CHANGES The bill makes numerous other changes throughout the statutes relating to APRNs, including various terminology changes. For further information see the state fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| AB263 | Coverage of breast cancer screenings by the Medical Assistance program and health insurance policies and plans. (FE) | This bill requires health insurance policies to provide coverage for diagnostic breast examinations and for supplemental breast screening examinations for an individual who is at increased risk of breast cancer, as determined in accordance with the most recent applicable guidelines of the National Comprehensive Cancer Network, or has heterogeneously or extremely dense breast tissue, as defined by the Breast Imaging-Reporting and Data System established by the American College of Radiology. Health insurance policies are referred to in the statutes as disability insurance policies. Self-insured governmental health plans are also required to provide the coverage specified in the bill. The bill also requires coverage of those breast screenings by the Medical Assistance program, which is the state- administered Medicaid program that is jointly funded by the state and federal governments and that provides health services to individuals with limited financial resources. Under the bill, health insurance policies may not charge a cost-sharing amount for a supplemental breast screening examination or diagnostic breast examination. The limitation on cost-sharing does not apply to the extent that the limitation would result in ineligibility for a health savings account under the federal Internal Revenue Code. Health insurance policies are required under current law to cover two mammographic breast examinations to screen for breast cancer for a woman from ages 45 to 49 if certain criteria are satisfied. Health insurance policies must currently cover annual mammograms for a woman once she attains the age of 50. The coverage required under current law is required whether or not the woman shows any symptoms of breast cancer and may be subject to only the same exclusions and limitations, including cost sharing, that apply to other radiological examinations under the policy. The bill does not change or eliminate the current coverage requirements for mammograms, except that preferred provider plans are explicitly included in the current law and the bill[s requirements. This proposal may contain a health insurance mandate requiring a social and financial impact report under s. 601.423, stats. For further information see the state fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| AB173 | Regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE) | This bill makes several changes to the regulation of pharmacy benefit managers and their interactions with pharmacies and pharmacists. Under current law, pharmacy benefit managers are generally required to be licensed as a pharmacy benefit manager or an employee benefit plan administrator by the commissioner of insurance. A pharmacy benefit manager is an entity that contracts to administer or manage prescription drug benefits on behalf of an insurer, a cooperative, or another entity that provides prescription drug benefits to Wisconsin residents. Major provisions of the bill are summarized below. Pharmacy benefit manager regulation The bill requires a pharmacy benefit manager to pay a pharmacy or pharmacist a professional dispensing fee at a rate not less than is paid by the state under the Medical Assistance program for each pharmaceutical product that the pharmacy or pharmacist dispenses to an individual. The professional dispensing fee is required to be paid in addition to the amount the pharmacy benefit manager reimburses the pharmacy or pharmacist for the cost of the pharmaceutical product that the pharmacy or pharmacist dispenses. The Medical Assistance program is a joint state and federal program that provides health services to individuals who have limited financial resources. The bill prohibits a pharmacy benefit manager from assessing, charging, or collecting from a pharmacy or pharmacist any form of remuneration that passes from the pharmacy or pharmacist to the pharmacy benefit manager including claim-processing fees, performance-based fees, network-participation fees, or accreditation fees. Further, under the bill, a pharmacy benefit manager may not use any certification or accreditation requirement as a determinant of pharmacy network participation that is inconsistent with, more stringent than, or in addition to the federal requirements for licensure as a pharmacy and the requirements for licensure as a pharmacy provided under state law. The bill requires a pharmacy benefit manager to allow a participant or beneficiary of a pharmacy benefits plan or program that the pharmacy benefit manager serves to use any pharmacy or pharmacist in this state that is licensed to dispense the pharmaceutical product that the participant or beneficiary seeks to obtain if the pharmacy or pharmacist accepts the same terms and conditions that the pharmacy benefit manager establishes for at least one of the networks of pharmacies or pharmacists that the pharmacy benefit manager has established to serve individuals in the state. A pharmacy benefit manager may establish a preferred network of pharmacies or pharmacists and a nonpreferred network of pharmacies or pharmacists; however, under the bill, a pharmacy benefit manager may not prohibit a pharmacy or pharmacist from participating in either type of network provided that the pharmacy or pharmacist is licensed by this state and the federal government and accepts the same terms and conditions that the pharmacy benefit manager establishes for other pharmacies or pharmacists participating in the network that the pharmacy or pharmacist wants to join. Under the bill, a pharmacy benefit manager may not charge a participant or beneficiary of a pharmacy benefits plan or program that the pharmacy benefit manager serves a different copayment obligation or additional fee, or provide any inducement or financial incentive, for the participant or beneficiary to use a pharmacy or pharmacist in a particular network of pharmacies or pharmacists that the pharmacy benefit manager has established to serve individuals in the state. Further, the bill prohibits a pharmacy benefit manager, third-party payer, or health benefit plan from excluding a pharmacy or pharmacist from its network because the pharmacy or pharmacist serves less than a certain portion of the population of the state or serves a population living with certain health conditions. The bill provides that a pharmacy benefit manager may neither prohibit a pharmacy or pharmacist that dispenses a pharmaceutical product from, nor penalize a pharmacy or pharmacist that dispenses a pharmaceutical product for, informing an individual about the cost of the pharmaceutical product, the amount in reimbursement that the pharmacy or pharmacist receives for dispensing the pharmaceutical product, or any difference between the cost to the individual under the individual[s pharmacy benefits plan or program and the cost to the individual if the individual purchases the pharmaceutical product without making a claim for benefits under the individual[s pharmacy benefits plan or program. The bill prohibits any pharmacy benefit manager or any insurer or self- insured health plan from requiring, or penalizing a person who is covered under a health insurance policy or plan for using or for not using, a specific retail, mail- order, or other pharmacy provider within the network of pharmacy providers under the policy or plan. Prohibited penalties include an increase in premium, deductible, copayment, or coinsurance. The bill requires pharmacy benefit managers to remit payment for a claim to a pharmacy or pharmacist within 30 days from the day that the claim is submitted to the pharmacy benefit manager by the pharmacy or pharmacist. Pharmaceutical product reimbursements The bill provides that a pharmacy benefit manager that uses a maximum allowable cost list must include all of the following information on the list: 1) the average acquisition cost of each pharmaceutical product and the cost of the pharmaceutical product set forth in the national average drug acquisition cost data published by the federal centers for medicare and medicaid services; 2) the average manufacturer price of each pharmaceutical product; 3) the average wholesale price of each pharmaceutical product; 4) the brand effective rate or generic effective rate for each pharmaceutical product; 5) any applicable discount indexing; 6) the federal upper limit for each pharmaceutical product published by the federal centers for medicare and medicaid services; pharmaceutical product; and 8) any other terms that are used to establish the maximum allowable costs. The bill provides that a pharmacy benefit manager may place or continue a particular pharmaceutical product on a maximum allowable cost list only if the pharmaceutical product 1) is listed as a drug product equivalent or is rated by a nationally recognized reference as Xnot ratedY or Xnot availableY; 2) is available for purchase by all pharmacies and pharmacists in the state from national or regional pharmaceutical wholesalers operating in the state; and 3) has not been determined by the drug manufacturer to be obsolete. Further, the bill provides that any pharmacy benefit manager that uses a maximum allowable cost list must provide access to the maximum allowable cost list to each pharmacy or pharmacist subject to the maximum allowable cost list, update the maximum allowable cost list on a timely basis, provide a process for a pharmacy or pharmacist subject to the maximum allowable cost list to receive notification of an update to the maximum allowable cost list, and update the maximum allowable cost list no later than seven days after the pharmacy acquisition cost of the pharmaceutical product increases by 10 percent or more from at least 60 percent of the pharmaceutical wholesalers doing business in the state or there is a change in the methodology on which the maximum allowable cost list is based or in the value of a variable involved in the methodology. A maximum allowable cost list is a list of pharmaceutical products that sets forth the maximum amount that a pharmacy benefit manager will pay to a pharmacy or pharmacist for dispensing a pharmaceutical product. A maximum allowable cost list may directly establish maximum costs or may set forth a method for how the maximum costs are calculated. The bill further provides that a pharmacy benefit manager that uses a maximum allowable cost list must provide a process for a pharmacy or pharmacist to appeal and resolve disputes regarding claims that the maximum payment amount for a pharmaceutical product is below the pharmacy acquisition cost. A pharmacy benefit manager that receives an appeal from or on behalf of a pharmacy or pharmacist under this bill is required to resolve the appeal and notify the pharmacy or pharmacist of the pharmacy benefit manager[s determination no later than seven business days after the appeal is received. If the pharmacy benefit manager grants the relief requested in the appeal, the bill requires the pharmacy benefit manager to make the requested change in the maximum allowable cost, allow the pharmacy or pharmacist to reverse and rebill the relevant claim, provide to the pharmacy or pharmacist the national drug code number published in a directory by the federal Food and Drug Administration on which the increase or change is based, and make the change effective for each similarly situated pharmacy or pharmacist subject to the maximum allowable cost list. If the pharmacy benefit manager denies the relief requested in the appeal, the bill requires the pharmacy benefit manager to provide the pharmacy or pharmacist a reason for the denial, the national drug code number published in a directory by the FDA for the pharmaceutical product to which the claim relates, and the name of a national or regional wholesaler that has the pharmaceutical product currently in stock at a price below the amount specified in the pharmacy benefit manager[s maximum allowable cost list. The bill provides that a pharmacy benefit manager may not deny a pharmacy[s or pharmacist[s appeal if the relief requested in the appeal relates to the maximum allowable cost for a pharmaceutical product that is not available for the pharmacy or pharmacist to purchase at a cost that is below the pharmacy acquisition cost from the pharmaceutical wholesaler from which the pharmacy or pharmacist purchases the majority of pharmaceutical products for resale. If a pharmaceutical product is not available for a pharmacy or pharmacist to purchase at a cost that is below the pharmacy acquisition cost from the pharmaceutical wholesaler from which the pharmacy or pharmacist purchases the majority of pharmaceutical products for resale, the pharmacy benefit manager must revise the maximum allowable cost list to increase the maximum allowable cost for the pharmaceutical product to an amount equal to or greater than the pharmacy[s or pharmacist[s pharmacy acquisition cost and allow the pharmacy or pharmacist to reverse and rebill each claim affected by the pharmacy[s or pharmacist[s inability to procure the pharmaceutical product at a cost that is equal to or less than the maximum allowable cost that was the subject of the pharmacy[s or pharmacist[s appeal. The bill prohibits a pharmacy benefit manager from reimbursing a pharmacy or pharmacist in the state an amount less than the amount that the pharmacy benefit manager reimburses a pharmacy benefit manager affiliate for providing the same pharmaceutical product. Under the bill, a pharmacy benefit manager affiliate is a pharmacy or pharmacist that is an affiliate of a pharmacy benefit manager. Finally, the bill allows a pharmacy or pharmacist to decline to provide a pharmaceutical product to an individual or pharmacy benefit manager if, as a result of a maximum allowable cost list, the pharmacy or pharmacist would be paid less than the pharmacy acquisition cost of the pharmacy or pharmacist providing the pharmaceutical product. Drug formularies This bill makes several changes with respect to drug formularies. Under current law, a disability insurance policy that offers a prescription drug benefit, a self-insured health plan that offers a prescription drug benefit, or a pharmacy benefit manager acting on behalf of a disability insurance policy or self-insured health plan must provide to an enrollee advanced written notice of a formulary change that removes a prescription drug from the formulary of the policy or plan or that reassigns a prescription drug to a benefit tier for the policy or plan that has a higher deductible, copayment, or coinsurance. The advanced written notice of a formulary change must be provided no fewer than 30 days before the expected date of the removal or reassignment. This bill provides that a disability insurance policy or self-insured health plan that provides a prescription drug benefit shall make the formulary and all drug costs associated with the formulary available to plan sponsors and individuals prior to selection or enrollment. Further, the bill provides that no disability insurance policy, self-insured health plan, or pharmacy benefit manager acting on behalf of a disability insurance policy or self-insured health plan may remove a prescription drug from the formulary except at the time of coverage renewal. Finally, the bill provides that advanced written notice of a formulary change must be provided no fewer than 90 days before the expected date of the removal or reassignment of a prescription drug on the formulary. Pharmacy networks Under the bill, if an enrollee utilizes a pharmacy or pharmacist in a preferred network of pharmacies or pharmacists, no disability insurance policy or self- insured health plan that provides a prescription drug benefit or pharmacy benefit manager that provides services under a contract with a policy or plan may require the enrollee to pay any amount or impose on the enrollee any condition that would not be required if the enrollee utilized a different pharmacy or pharmacist in the same preferred network. Further, the bill provides that any disability insurance policy or self-insured health plan that provides a prescription drug benefit, or any pharmacy benefit manager that provides services under a contract with a policy or plan, that has established a preferred network of pharmacies or pharmacists must reimburse each pharmacy or pharmacist in the same network at the same rates. Audits of pharmacists and pharmacies This bill makes several changes to audits of pharmacists and pharmacies. The bill requires an entity that conducts audits of pharmacists and pharmacies to ensure that each pharmacist or pharmacy audited by the entity is audited under the same standards and parameters as other similarly situated pharmacists or pharmacies audited by the entity, that the entity randomizes the prescriptions that the entity audits and the entity audits the same number of prescriptions in each prescription benefit tier, and that each audit of a prescription reimbursed under Part D of the federal Medicare program is conducted separately from audits of prescriptions reimbursed under other policies or plans. The bill prohibits any pharmacy benefit manager from recouping reimbursements made to a pharmacist or pharmacy for errors that involve no actual financial harm to an enrollee or a policy or plan sponsor unless the error is the result of the pharmacist or pharmacy failing to comply with a formal corrective action plan. The bill further prohibits any pharmacy benefit manager from using extrapolation in calculating reimbursements that it may recoup, and instead requires a pharmacy benefit manager to base the finding of errors for which reimbursements will be recouped on an actual error in reimbursement and not a projection of the number of patients served having a similar diagnosis or on a projection of the number of similar orders or refills for similar prescription drugs. The bill provides that a pharmacy benefit manager that recoups any reimbursements made to a pharmacist or pharmacy for an error that was the cause of financial harm must return the recouped reimbursement to the enrollee or the policy or plan sponsor who was harmed by the error. Pharmacy benefit manager fiduciary and disclosure requirements The bill provides that a pharmacy benefit manager owes a fiduciary duty to a health benefit plan sponsor. The bill also requires that a pharmacy benefit manager annually disclose all of the following information to the health benefit plan sponsor: 1. The indirect profit received by the pharmacy benefit manager from owning a pharmacy or health service provider. 2. Any payments made to a consultant or broker who works on behalf of the plan sponsor. 3. From the amounts received from drug manufacturers, the amounts retained by the pharmacy benefit manager that are related to the plan sponsor[s claims or bona fide service fees. 4. The amounts received from network pharmacies and pharmacists and the amount retained by the pharmacy benefit manager. Discriminatory reimbursement of 340B entities The bill prohibits a pharmacy benefit manager from taking certain actions with respect to 340B covered entities, pharmacies and pharmacists contracted with 340B covered entities, and patients who obtain prescription drugs from 340B covered entities. The 340B drug pricing program is a federal program that requires pharmaceutical manufacturers that participate in the federal Medicaid program to sell outpatient drugs at discounted prices to certain health care organizations that provide health care for uninsured and low-income patients. Entities that are eligible for discounted prices under the 340B drug pricing program include federally qualified health centers, critical access hospitals, and certain public and nonprofit disproportionate share hospitals. The bill prohibits pharmacy benefit managers from doing any of the following: 1. Refusing to reimburse a 340B covered entity or a pharmacy or pharmacist contracted with a 340B covered entity for dispensing 340B drugs. 2. Imposing requirements or restrictions on 340B covered entities or pharmacies or pharmacists contracted with 340B covered entities that are not imposed on other entities, pharmacies, or pharmacists. 3. Reimbursing a 340B covered entity or a pharmacy or pharmacist contracted with a 340B covered entity for a 340B drug at a rate lower than the amount paid for the same drug to pharmacies or pharmacists that are not 340B covered entities or pharmacies or pharmacists contracted with a 340B covered entity. 4. Assessing a fee, charge back, or other adjustment against a 340B covered entity or a pharmacy or pharmacist contracted with a 340B covered entity after a claim has been paid or adjudicated. 5. Restricting the access of a 340B covered entity or a pharmacy or pharmacist contracted with a 340B covered entity to a third-party payer[s pharmacy network solely because the 340B covered entity or the pharmacy or pharmacist contracted with a 340B covered entity participates in the 340B drug pricing program. 6. Requiring a 340B covered entity or a pharmacy or pharmacist contracted with a 340B covered entity to contract with a specific pharmacy or pharmacist or health benefit plan in order to access a third-party payer[s pharmacy network. 7. Imposing a restriction or an additional charge on a patient who obtains a 340B drug from a 340B covered entity or a pharmacy or pharmacist contracted with a 340B covered entity. 8. Restricting the methods by which a 340B covered entity or a pharmacy or pharmacist contracted with a 340B covered entity may dispense or deliver 340B drugs. 9. Requiring a 340B covered entity or a pharmacy or pharmacist contracted with a 340B covered entity to share pharmacy bills or invoices with a pharmacy benefit manager, a third-party payer, or a health benefit plan. Application of prescription drug payments Health insurance policies and plans often apply cost-sharing requirements and out-of-pocket maximum amounts to the benefits covered by the policy or plan. A cost-sharing requirement is a share of covered benefits that an insured is required to pay under a health insurance policy or plan. Cost-sharing requirements include copayments, deductibles, and coinsurance. An out-of-pocket maximum amount is a limit specified by a policy or plan on the amount that an insured pays, and, once that limit is reached, the policy or plan covers the benefit entirely. The bill generally requires health insurance policies that offer prescription drug benefits, self-insured health plans, and pharmacy benefit managers acting on behalf of policies or plans to apply amounts paid by or on behalf of an individual covered under the policy or plan for brand name prescription drugs to any cost- sharing requirement or to any calculation of an out-of-pocket maximum amount of the policy or plan. Health insurance policies are referred to in the bill as disability insurance policies. Prohibited retaliation The bill prohibits a pharmacy benefit manager from retaliating against a pharmacy or pharmacist for reporting an alleged violation of certain laws applicable to pharmacy benefit managers or for exercising certain rights or remedies. Retaliation includes terminating or refusing to renew a contract with a pharmacy or pharmacist, subjecting a pharmacy or pharmacist to increased audits, or failing to promptly pay a pharmacy or pharmacist any money that the pharmacy benefit manager owes to the pharmacy or pharmacist. The bill provides that a pharmacy or pharmacist may bring an action in court for injunctive relief if a pharmacy benefit manager is retaliating against the pharmacy or pharmacist as provided in the bill. In addition to equitable relief, the court may award a pharmacy or pharmacist that prevails in such an action reasonable attorney fees and costs. For further information see the state fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| SB203 | Regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE) | This bill makes several changes to the regulation of pharmacy benefit LRB-1278/1 JPC:cjs&skw 2025 - 2026 Legislature SENATE BILL 203 managers and their interactions with pharmacies and pharmacists. Under current law, pharmacy benefit managers are generally required to be licensed as a pharmacy benefit manager or an employee benefit plan administrator by the commissioner of insurance. A pharmacy benefit manager is an entity that contracts to administer or manage prescription drug benefits on behalf of an insurer, a cooperative, or another entity that provides prescription drug benefits to Wisconsin residents. Major provisions of the bill are summarized below. Pharmacy benefit manager regulation The bill requires a pharmacy benefit manager to pay a pharmacy or pharmacist a professional dispensing fee at a rate not less than is paid by the state under the Medical Assistance program for each pharmaceutical product that the pharmacy or pharmacist dispenses to an individual. The professional dispensing fee is required to be paid in addition to the amount the pharmacy benefit manager reimburses the pharmacy or pharmacist for the cost of the pharmaceutical product that the pharmacy or pharmacist dispenses. The Medical Assistance program is a joint state and federal program that provides health services to individuals who have limited financial resources. The bill prohibits a pharmacy benefit manager from assessing, charging, or collecting from a pharmacy or pharmacist any form of remuneration that passes from the pharmacy or pharmacist to the pharmacy benefit manager including claim-processing fees, performance-based fees, network-participation fees, or accreditation fees. Further, under the bill, a pharmacy benefit manager may not use any certification or accreditation requirement as a determinant of pharmacy network participation that is inconsistent with, more stringent than, or in addition to the federal requirements for licensure as a pharmacy and the requirements for licensure as a pharmacy provided under state law. The bill requires a pharmacy benefit manager to allow a participant or beneficiary of a pharmacy benefits plan or program that the pharmacy benefit manager serves to use any pharmacy or pharmacist in this state that is licensed to dispense the pharmaceutical product that the participant or beneficiary seeks to obtain if the pharmacy or pharmacist accepts the same terms and conditions that the pharmacy benefit manager establishes for at least one of the networks of pharmacies or pharmacists that the pharmacy benefit manager has established to serve individuals in the state. A pharmacy benefit manager may establish a preferred network of pharmacies or pharmacists and a nonpreferred network of pharmacies or pharmacists; however, under the bill, a pharmacy benefit manager may not prohibit a pharmacy or pharmacist from participating in either type of network provided that the pharmacy or pharmacist is licensed by this state and the federal government and accepts the same terms and conditions that the pharmacy benefit manager establishes for other pharmacies or pharmacists participating in the network that the pharmacy or pharmacist wants to join. Under the bill, a pharmacy benefit manager may not charge a participant or beneficiary of a LRB-1278/1 JPC:cjs&skw 2025 - 2026 Legislature SENATE BILL 203 pharmacy benefits plan or program that the pharmacy benefit manager serves a different copayment obligation or additional fee, or provide any inducement or financial incentive, for the participant or beneficiary to use a pharmacy or pharmacist in a particular network of pharmacies or pharmacists that the pharmacy benefit manager has established to serve individuals in the state. Further, the bill prohibits a pharmacy benefit manager, third-party payer, or health benefit plan from excluding a pharmacy or pharmacist from its network because the pharmacy or pharmacist serves less than a certain portion of the population of the state or serves a population living with certain health conditions. The bill provides that a pharmacy benefit manager may neither prohibit a pharmacy or pharmacist that dispenses a pharmaceutical product from, nor penalize a pharmacy or pharmacist that dispenses a pharmaceutical product for, informing an individual about the cost of the pharmaceutical product, the amount in reimbursement that the pharmacy or pharmacist receives for dispensing the pharmaceutical product, or any difference between the cost to the individual under the individual[s pharmacy benefits plan or program and the cost to the individual if the individual purchases the pharmaceutical product without making a claim for benefits under the individual[s pharmacy benefits plan or program. The bill prohibits any pharmacy benefit manager or any insurer or self- insured health plan from requiring, or penalizing a person who is covered under a health insurance policy or plan for using or for not using, a specific retail, mail- order, or other pharmacy provider within the network of pharmacy providers under the policy or plan. Prohibited penalties include an increase in premium, deductible, copayment, or coinsurance. The bill requires pharmacy benefit managers to remit payment for a claim to a pharmacy or pharmacist within 30 days from the day that the claim is submitted to the pharmacy benefit manager by the pharmacy or pharmacist. Pharmaceutical product reimbursements The bill provides that a pharmacy benefit manager that uses a maximum allowable cost list must include all of the following information on the list: 1) the average acquisition cost of each pharmaceutical product and the cost of the pharmaceutical product set forth in the national average drug acquisition cost data published by the federal centers for medicare and medicaid services; 2) the average manufacturer price of each pharmaceutical product; 3) the average wholesale price of each pharmaceutical product; 4) the brand effective rate or generic effective rate for each pharmaceutical product; 5) any applicable discount indexing; 6) the federal upper limit for each pharmaceutical product published by the federal centers for medicare and medicaid services; pharmaceutical product; and 8) any other terms that are used to establish the maximum allowable costs. The bill provides that a pharmacy benefit manager may place or continue a particular pharmaceutical product on a maximum allowable cost list only if the pharmaceutical product 1) is listed as a drug product equivalent or is rated by a LRB-1278/1 JPC:cjs&skw 7) the wholesale acquisition cost of each 2025 - 2026 Legislature SENATE BILL 203 nationally recognized reference as Xnot ratedY or Xnot availableY; 2) is available for purchase by all pharmacies and pharmacists in the state from national or regional pharmaceutical wholesalers operating in the state; and 3) has not been determined by the drug manufacturer to be obsolete. Further, the bill provides that any pharmacy benefit manager that uses a maximum allowable cost list must provide access to the maximum allowable cost list to each pharmacy or pharmacist subject to the maximum allowable cost list, update the maximum allowable cost list on a timely basis, provide a process for a pharmacy or pharmacist subject to the maximum allowable cost list to receive notification of an update to the maximum allowable cost list, and update the maximum allowable cost list no later than seven days after the pharmacy acquisition cost of the pharmaceutical product increases by 10 percent or more from at least 60 percent of the pharmaceutical wholesalers doing business in the state or there is a change in the methodology on which the maximum allowable cost list is based or in the value of a variable involved in the methodology. A maximum allowable cost list is a list of pharmaceutical products that sets forth the maximum amount that a pharmacy benefit manager will pay to a pharmacy or pharmacist for dispensing a pharmaceutical product. A maximum allowable cost list may directly establish maximum costs or may set forth a method for how the maximum costs are calculated. The bill further provides that a pharmacy benefit manager that uses a maximum allowable cost list must provide a process for a pharmacy or pharmacist to appeal and resolve disputes regarding claims that the maximum payment amount for a pharmaceutical product is below the pharmacy acquisition cost. A pharmacy benefit manager that receives an appeal from or on behalf of a pharmacy or pharmacist under this bill is required to resolve the appeal and notify the pharmacy or pharmacist of the pharmacy benefit manager[s determination no later than seven business days after the appeal is received. If the pharmacy benefit manager grants the relief requested in the appeal, the bill requires the pharmacy benefit manager to make the requested change in the maximum allowable cost, allow the pharmacy or pharmacist to reverse and rebill the relevant claim, provide to the pharmacy or pharmacist the national drug code number published in a directory by the federal Food and Drug Administration on which the increase or change is based, and make the change effective for each similarly situated pharmacy or pharmacist subject to the maximum allowable cost list. If the pharmacy benefit manager denies the relief requested in the appeal, the bill requires the pharmacy benefit manager to provide the pharmacy or pharmacist a reason for the denial, the national drug code number published in a directory by the FDA for the pharmaceutical product to which the claim relates, and the name of a national or regional wholesaler that has the pharmaceutical product currently in stock at a price below the amount specified in the pharmacy benefit manager[s maximum allowable cost list. The bill provides that a pharmacy benefit manager may not deny a pharmacy[s or pharmacist[s appeal if the relief requested in the appeal relates to LRB-1278/1 JPC:cjs&skw 2025 - 2026 Legislature SENATE BILL 203 the maximum allowable cost for a pharmaceutical product that is not available for the pharmacy or pharmacist to purchase at a cost that is below the pharmacy acquisition cost from the pharmaceutical wholesaler from which the pharmacy or pharmacist purchases the majority of pharmaceutical products for resale. If a pharmaceutical product is not available for a pharmacy or pharmacist to purchase at a cost that is below the pharmacy acquisition cost from the pharmaceutical wholesaler from which the pharmacy or pharmacist purchases the majority of pharmaceutical products for resale, the pharmacy benefit manager must revise the maximum allowable cost list to increase the maximum allowable cost for the pharmaceutical product to an amount equal to or greater than the pharmacy[s or pharmacist[s pharmacy acquisition cost and allow the pharmacy or pharmacist to reverse and rebill each claim affected by the pharmacy[s or pharmacist[s inability to procure the pharmaceutical product at a cost that is equal to or less than the maximum allowable cost that was the subject of the pharmacy[s or pharmacist[s appeal. The bill prohibits a pharmacy benefit manager from reimbursing a pharmacy or pharmacist in the state an amount less than the amount that the pharmacy benefit manager reimburses a pharmacy benefit manager affiliate for providing the same pharmaceutical product. Under the bill, a pharmacy benefit manager affiliate is a pharmacy or pharmacist that is an affiliate of a pharmacy benefit manager. Finally, the bill allows a pharmacy or pharmacist to decline to provide a pharmaceutical product to an individual or pharmacy benefit manager if, as a result of a maximum allowable cost list, the pharmacy or pharmacist would be paid less than the pharmacy acquisition cost of the pharmacy or pharmacist providing the pharmaceutical product. Drug formularies This bill makes several changes with respect to drug formularies. Under current law, a disability insurance policy that offers a prescription drug benefit, a self-insured health plan that offers a prescription drug benefit, or a pharmacy benefit manager acting on behalf of a disability insurance policy or self-insured health plan must provide to an enrollee advanced written notice of a formulary change that removes a prescription drug from the formulary of the policy or plan or that reassigns a prescription drug to a benefit tier for the policy or plan that has a higher deductible, copayment, or coinsurance. The advanced written notice of a formulary change must be provided no fewer than 30 days before the expected date of the removal or reassignment. This bill provides that a disability insurance policy or self-insured health plan that provides a prescription drug benefit shall make the formulary and all drug costs associated with the formulary available to plan sponsors and individuals prior to selection or enrollment. Further, the bill provides that no disability insurance policy, self-insured health plan, or pharmacy benefit manager acting on behalf of a disability insurance policy or self-insured health plan may remove a prescription LRB-1278/1 JPC:cjs&skw 2025 - 2026 Legislature SENATE BILL 203 drug from the formulary except at the time of coverage renewal. Finally, the bill provides that advanced written notice of a formulary change must be provided no fewer than 90 days before the expected date of the removal or reassignment of a prescription drug on the formulary. Pharmacy networks Under the bill, if an enrollee utilizes a pharmacy or pharmacist in a preferred network of pharmacies or pharmacists, no disability insurance policy or self- insured health plan that provides a prescription drug benefit or pharmacy benefit manager that provides services under a contract with a policy or plan may require the enrollee to pay any amount or impose on the enrollee any condition that would not be required if the enrollee utilized a different pharmacy or pharmacist in the same preferred network. Further, the bill provides that any disability insurance policy or self-insured health plan that provides a prescription drug benefit, or any pharmacy benefit manager that provides services under a contract with a policy or plan, that has established a preferred network of pharmacies or pharmacists must reimburse each pharmacy or pharmacist in the same network at the same rates. Audits of pharmacists and pharmacies This bill makes several changes to audits of pharmacists and pharmacies. The bill requires an entity that conducts audits of pharmacists and pharmacies to ensure that each pharmacist or pharmacy audited by the entity is audited under the same standards and parameters as other similarly situated pharmacists or pharmacies audited by the entity, that the entity randomizes the prescriptions that the entity audits and the entity audits the same number of prescriptions in each prescription benefit tier, and that each audit of a prescription reimbursed under Part D of the federal Medicare program is conducted separately from audits of prescriptions reimbursed under other policies or plans. The bill prohibits any pharmacy benefit manager from recouping reimbursements made to a pharmacist or pharmacy for errors that involve no actual financial harm to an enrollee or a policy or plan sponsor unless the error is the result of the pharmacist or pharmacy failing to comply with a formal corrective action plan. The bill further prohibits any pharmacy benefit manager from using extrapolation in calculating reimbursements that it may recoup, and instead requires a pharmacy benefit manager to base the finding of errors for which reimbursements will be recouped on an actual error in reimbursement and not a projection of the number of patients served having a similar diagnosis or on a projection of the number of similar orders or refills for similar prescription drugs. The bill provides that a pharmacy benefit manager that recoups any reimbursements made to a pharmacist or pharmacy for an error that was the cause of financial harm must return the recouped reimbursement to the enrollee or the policy or plan sponsor who was harmed by the error. Pharmacy benefit manager fiduciary and disclosure requirements The bill provides that a pharmacy benefit manager owes a fiduciary duty to a health benefit plan sponsor. The bill also requires that a pharmacy benefit LRB-1278/1 JPC:cjs&skw 2025 - 2026 Legislature SENATE BILL 203 manager annually disclose all of the following information to the health benefit plan sponsor: 1. The indirect profit received by the pharmacy benefit manager from owning a pharmacy or health service provider. 2. Any payments made to a consultant or broker who works on behalf of the plan sponsor. 3. From the amounts received from drug manufacturers, the amounts retained by the pharmacy benefit manager that are related to the plan sponsor[s claims or bona fide service fees. 4. The amounts received from network pharmacies and pharmacists and the amount retained by the pharmacy benefit manager. Discriminatory reimbursement of 340B entities The bill prohibits a pharmacy benefit manager from taking certain actions with respect to 340B covered entities, pharmacies and pharmacists contracted with 340B covered entities, and patients who obtain prescription drugs from 340B covered entities. The 340B drug pricing program is a federal program that requires pharmaceutical manufacturers that participate in the federal Medicaid program to sell outpatient drugs at discounted prices to certain health care organizations that provide health care for uninsured and low-income patients. Entities that are eligible for discounted prices under the 340B drug pricing program include federally qualified health centers, critical access hospitals, and certain public and nonprofit disproportionate share hospitals. The bill prohibits pharmacy benefit managers from doing any of the following: 1. Refusing to reimburse a 340B covered entity or a pharmacy or pharmacist contracted with a 340B covered entity for dispensing 340B drugs. 2. Imposing requirements or restrictions on 340B covered entities or pharmacies or pharmacists contracted with 340B covered entities that are not imposed on other entities, pharmacies, or pharmacists. 3. Reimbursing a 340B covered entity or a pharmacy or pharmacist contracted with a 340B covered entity for a 340B drug at a rate lower than the amount paid for the same drug to pharmacies or pharmacists that are not 340B covered entities or pharmacies or pharmacists contracted with a 340B covered entity. 4. Assessing a fee, charge back, or other adjustment against a 340B covered entity or a pharmacy or pharmacist contracted with a 340B covered entity after a claim has been paid or adjudicated. 5. Restricting the access of a 340B covered entity or a pharmacy or pharmacist contracted with a 340B covered entity to a third-party payer[s pharmacy network solely because the 340B covered entity or the pharmacy or pharmacist contracted with a 340B covered entity participates in the 340B drug pricing program. 6. Requiring a 340B covered entity or a pharmacy or pharmacist contracted LRB-1278/1 JPC:cjs&skw 2025 - 2026 Legislature SENATE BILL 203 with a 340B covered entity to contract with a specific pharmacy or pharmacist or health benefit plan in order to access a third-party payer[s pharmacy network. 7. Imposing a restriction or an additional charge on a patient who obtains a 340B drug from a 340B covered entity or a pharmacy or pharmacist contracted with a 340B covered entity. 8. Restricting the methods by which a 340B covered entity or a pharmacy or pharmacist contracted with a 340B covered entity may dispense or deliver 340B drugs. 9. Requiring a 340B covered entity or a pharmacy or pharmacist contracted with a 340B covered entity to share pharmacy bills or invoices with a pharmacy benefit manager, a third-party payer, or a health benefit plan. Application of prescription drug payments Health insurance policies and plans often apply cost-sharing requirements and out-of-pocket maximum amounts to the benefits covered by the policy or plan. A cost-sharing requirement is a share of covered benefits that an insured is required to pay under a health insurance policy or plan. Cost-sharing requirements include copayments, deductibles, and coinsurance. An out-of-pocket maximum amount is a limit specified by a policy or plan on the amount that an insured pays, and, once that limit is reached, the policy or plan covers the benefit entirely. The bill generally requires health insurance policies that offer prescription drug benefits, self-insured health plans, and pharmacy benefit managers acting on behalf of policies or plans to apply amounts paid by or on behalf of an individual covered under the policy or plan for brand name prescription drugs to any cost- sharing requirement or to any calculation of an out-of-pocket maximum amount of the policy or plan. Health insurance policies are referred to in the bill as disability insurance policies. Prohibited retaliation The bill prohibits a pharmacy benefit manager from retaliating against a pharmacy or pharmacist for reporting an alleged violation of certain laws applicable to pharmacy benefit managers or for exercising certain rights or remedies. Retaliation includes terminating or refusing to renew a contract with a pharmacy or pharmacist, subjecting a pharmacy or pharmacist to increased audits, or failing to promptly pay a pharmacy or pharmacist any money that the pharmacy benefit manager owes to the pharmacy or pharmacist. The bill provides that a pharmacy or pharmacist may bring an action in court for injunctive relief if a pharmacy benefit manager is retaliating against the pharmacy or pharmacist as provided in the bill. In addition to equitable relief, the court may award a pharmacy or pharmacist that prevails in such an action reasonable attorney fees and costs. For further information see the state fiscal estimate, which will be printed as an appendix to this bill. LRB-1278/1 JPC:cjs&skw 2025 - 2026 Legislature SENATE BILL 203 | In Committee |
| SB212 | The form of referendum questions. | Under current law, any referendum question submitted to the voters, including to approve or reject a constitutional amendment, must be concise and may not be worded in such a manner as to require a negative vote to approve a proposition or an affirmative vote to disapprove a proposition. This bill adds the requirement that the referendum question be in plain language. The bill additionally adds the requirement that for a proposed constitutional amendment, the question must clearly indicate whether any part of the constitutional amendment is contained in the statutes as of the date of final passage of the joint resolution directing that the question be submitted to a vote of the people. | In Committee |
| AB224 | The form of referendum questions. | Under current law, any referendum question submitted to the voters, including to approve or reject a constitutional amendment, must be concise and may not be worded in such a manner as to require a negative vote to approve a proposition or an affirmative vote to disapprove a proposition. This bill adds the requirement that the referendum question be in plain language. The bill additionally adds the requirement that for a proposed constitutional amendment, the question must clearly indicate whether any part of the constitutional amendment is contained in the statutes as of the date of final passage of the joint resolution directing that the question be submitted to a vote of the people. | In Committee |
| SB74 | Ratification of the Social Work Licensure Compact. (FE) | This bill ratifies and enters Wisconsin into the Social Work Licensure Compact, which provides for the ability of a social worker to become eligible to LRB-1310/1 MED:emw 2025 - 2026 Legislature SENATE BILL 74 practice in other compact states. Significant provisions of the compact include the following: 1. The creation of a Social Work Licensure Compact Commission, which includes one member or administrator of the licensure authorities of each member state. The commission has various powers and duties granted in the compact, including establishing bylaws, promulgating binding rules for the compact, hiring officers, electing or appointing employees, and establishing and electing an executive committee. The commission may levy on and collect an annual assessment from each member state or impose fees on licensees of member states to cover the cost of the operations and activities of the commission and its staff. 2. The ability for a social worker who is licensed in a home state and satisfies certain other criteria to obtain a multistate license, which allows a social worker to practice social work in all other compact states (remote states) under a multistate authorization to practice. The compact specifies a number of requirements in order for an individual to obtain a social worker multistate license, including holding or being eligible for a social worker license in a home state, paying any required fees, and satisfying a number of criteria that are specific to the category of social work license the individual is seeking—bachelor[s, master[s, or clinical. A regulated social worker[s services in a remote state are subject to that member state[s regulatory authority. A remote state may take actions against a social worker[s multistate authorization to practice within that remote state, and if any adverse action is taken by a home state against a licensee[s multistate license, the social worker[s multistate authorization to practice in all other member states is deactivated until all encumbrances have been removed from the multistate license. 3. The ability of member states to issue subpoenas that are enforceable in other states. 4. The creation of a coordinated data system containing licensure and disciplinary action information on social workers. The compact requires all home state disciplinary orders that impose adverse actions against the license of a regulated social worker to include a statement that the regulated social worker[s multistate authorization to practice is deactivated in all member states until all conditions of the decision, order, or agreement are satisfied. A member state must submit a uniform data set to the data system on all individuals to whom the compact is applicable as required by the rules of the commission. 5. Provisions regarding resolutions of disputes among member states and between member and nonmember states, including a process for termination of a state[s membership in the compact if the state defaults on its obligations under the compact. Since the compact has already been enacted by the minimum number of states required for it to become active, the compact becomes effective in this state upon enactment of the bill. The compact provides that it may be amended upon enactment of an amendment by all member states. A state may withdraw from the compact by repealing the statute authorizing the compact, but the compact provides LRB-1310/1 MED:emw 2025 - 2026 Legislature SENATE BILL 74 that a withdrawal does not take effect until 180 days after the effective date of that repeal. For further information see the state fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| SB264 | Coverage of breast cancer screenings by the Medical Assistance program and health insurance policies and plans. (FE) | This bill requires health insurance policies to provide coverage for diagnostic breast examinations and for supplemental breast screening examinations for an individual who is at increased risk of breast cancer, as determined in accordance with the most recent applicable guidelines of the National Comprehensive Cancer Network, or has heterogeneously or extremely dense breast tissue, as defined by the Breast Imaging-Reporting and Data System established by the American College of Radiology. Health insurance policies are referred to in the statutes as disability insurance policies. Self-insured governmental health plans are also required to LRB-3021/1 JPC&SWB:cdc 2025 - 2026 Legislature SENATE BILL 264 provide the coverage specified in the bill. The bill also requires coverage of those breast screenings by the Medical Assistance program, which is the state- administered Medicaid program that is jointly funded by the state and federal governments and that provides health services to individuals with limited financial resources. Under the bill, health insurance policies may not charge a cost-sharing amount for a supplemental breast screening examination or diagnostic breast examination. The limitation on cost-sharing does not apply to the extent that the limitation would result in ineligibility for a health savings account under the federal Internal Revenue Code. Health insurance policies are required under current law to cover two mammographic breast examinations to screen for breast cancer for a woman from ages 45 to 49 if certain criteria are satisfied. Health insurance policies must currently cover annual mammograms for a woman once she attains the age of 50. The coverage required under current law is required whether or not the woman shows any symptoms of breast cancer and may be subject to only the same exclusions and limitations, including cost sharing, that apply to other radiological examinations under the policy. The bill does not change or eliminate the current coverage requirements for mammograms, except that preferred provider plans are explicitly included in the current law and the bill[s requirements. This proposal may contain a health insurance mandate requiring a social and financial impact report under s. 601.423, stats. For further information see the state fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| SB2 | Expanding veterans benefits to individuals who served in Laos in support of the United States during the Vietnam War. | This bill expands the definition of “veteran” to include individuals who were naturalized pursuant to the Hmong Veterans’ Naturalization Act of 2000. The bill extends most veterans benefits to anyone who meets this newly expanded definition of veteran, however, admission to a state veterans home and burial in a veterans cemetery are not included benefits as they are subject to federal regulation. | Crossed Over |
| SB23 | Extension of eligibility under the Medical Assistance program for postpartum women. (FE) | This bill requires the Department of Health Services to seek approval from the federal Department of Health and Human Services to extend until the last day of the month in which the 365th day after the last day of the pregnancy falls Medical Assistance benefits to women who are eligible for those benefits when pregnant. Currently, postpartum women are eligible for Medical Assistance benefits until the last day of the month in which the 60th day after the last day of the pregnancy falls. 2021 Wisconsin Act 58 required DHS to seek approval from the federal Department of Health and Human Services to extend these postpartum Medical Assistance benefits until the last day of the month in which the 90th day after the last day of the pregnancy falls. On June 3, 2022, DHS filed a Section 1115 Demonstration Waiver application with the federal Centers for Medicare & Medicaid Services to extend postpartum coverage for eligible Medical Assistance recipients, as required by 2021 Wisconsin Act 58. The Medical Assistance program is a joint federal and state program that provides health services to individuals who have limited financial resources. LRB-0926/1 JPC:cdc 2025 - 2026 Legislature SENATE BILL 23 For further information see the state fiscal estimate, which will be printed as an appendix to this bill. | Crossed Over |
| SJR30 | Congratulating the University of Wisconsin–Madison women’s hockey team on winning the 2025 NCAA Division I Women’s Hockey National Championship. | Relating to: congratulating the University of Wisconsin]Madison women[s hockey team on winning the 2025 NCAA Division I Women[s Hockey National Championship. | Crossed Over |
| AB40 | School safety grants and making an appropriation. (FE) | This bill requires the Office of School Safety in the Department of Justice to establish a competitive grant program that is open to public and private schools for grants to improve the safety of school buildings and to provide security training to school personnel. In administering the program, the Office of School Safety must give preference to applicants that have not yet received a school safety grant from DOJ. The bill provides $30,000,000 for these grants and specifies that the maximum amount DOJ may award to an applicant is $20,000. The bill also requires the Office of School Safety to submit an annual report related to these grants to the Joint Committee on Finance. Finally, the grant program sunsets on July 1, 2027. For further information see the state fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| SB246 | A special observance day in schools for Armenian Genocide Awareness Day. | This bill adds April 24, Armenian Genocide Awareness Day, to the list of special observance days that apply to general school operations. Current law provides a list of 22 special observance days, including Dr. Martin Luther King, Jr. Day; Susan B. Anthony[s birthday; Environmental Awareness Day; Bullying Awareness Day; and Veterans Day. Under current law, a special observance day must be appropriately observed when school is held on that day or, if the day falls on a Saturday or Sunday, on the school day immediately preceding or following the special observance day. | In Committee |
| SB247 | Local and private regulation of accessory dwelling units. (FE) | This bill requires political subdivisions with zoning ordinances to allow as a use permitted by right at least one accessory dwelling unit (ADU) on each parcel on which single-family or multi-family residential use is a use permitted by right. The bill also prohibits political subdivisions from doing any of the following: 1. Charging fees, other than standard building permit fees, related to the addition of an ADU to a parcel. 2. Providing dimensional, physical, design, or locational requirements that apply to ADUs, but do not apply to single-family dwellings. 3. Providing standards, other than standards relating to habitability, that apply to ADUs but do not apply to other accessory structures. 4. Imposing any additional parking requirements to parcels on the basis of the existence of an ADU. 5. Requiring the installation of a separate utility connection to an ADU. The bill also provides that any covenant, restriction, or condition contained in a deed or other instrument affecting real property that prohibits or unreasonably restricts the construction, maintenance, or use of an ADU is void and unenforceable and prohibits a homeowners[ association from restricting or preventing the construction, maintenance, or use of an ADU, except to the extent necessary to protect public health and safety. LRB-0105/1 EVM&KRP:amn&wlj 2025 - 2026 Legislature SENATE BILL 247 Because this bill may increase or decrease, directly or indirectly, the cost of the development, construction, financing, purchasing, sale, ownership, or availability of housing in this state, the Department of Administration, as required by law, will prepare a report to be printed as an appendix to this bill. For further information see the local fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| AB256 | A special observance day in schools for Armenian Genocide Awareness Day. | This bill adds April 24, Armenian Genocide Awareness Day, to the list of special observance days that apply to general school operations. Current law provides a list of 22 special observance days, including Dr. Martin Luther King, Jr. Day; Susan B. Anthony[s birthday; Environmental Awareness Day; Bullying Awareness Day; and Veterans Day. Under current law, a special observance day must be appropriately observed when school is held on that day or, if the day falls on a Saturday or Sunday, on the school day immediately preceding or following the special observance day. | In Committee |
| SB261 | Certain limitations on claiming the veterans and surviving spouses property tax credit. (FE) | Under current law, a person who claims the farmland preservation tax credit is prohibited from claiming the veterans and surviving spouses property tax credit in the same tax year. This bill allows a person to claim both the farmland preservation tax credit and the veterans and surviving spouses property tax credit in the same tax year. Current law allows a person to claim a farmland preservation income tax credit for the person[s land engaged in an agricultural use, if the land is covered by a farmland preservation agreement, located in a farmland preservation zoning district, or covered by an agricultural conservation easement. Also, under current law, an eligible veteran or surviving spouse may claim a refundable income tax credit that equals the amount of property taxes paid during the year on the claimant[s principal dwelling in Wisconsin. For further information see the state fiscal estimate, which will be printed as an appendix to this bill. LRB-2781/1 KP:cdc 2025 - 2026 Legislature SENATE BILL 261 | In Committee |
| AB264 | Certain limitations on claiming the veterans and surviving spouses property tax credit. (FE) | Under current law, a person who claims the farmland preservation tax credit is prohibited from claiming the veterans and surviving spouses property tax credit in the same tax year. This bill allows a person to claim both the farmland preservation tax credit and the veterans and surviving spouses property tax credit in the same tax year. Current law allows a person to claim a farmland preservation income tax credit for the person[s land engaged in an agricultural use, if the land is covered by a farmland preservation agreement, located in a farmland preservation zoning district, or covered by an agricultural conservation easement. Also, under current law, an eligible veteran or surviving spouse may claim a refundable income tax credit that equals the amount of property taxes paid during the year on the claimant[s principal dwelling in Wisconsin. For further information see the state fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| AB27 | Expanding veterans benefits to individuals who served in Laos in support of the United States during the Vietnam War. | This bill expands the definition of XveteranY to include individuals who were naturalized pursuant to the Hmong Veterans[ Naturalization Act of 2000. The bill extends most veterans benefits to anyone who meets this newly expanded definition of veteran, however, admission to a state veterans home and burial in a veterans cemetery are not included benefits as they are subject to federal regulation. | In Committee |
| SB41 | School safety grants and making an appropriation. (FE) | This bill requires the Office of School Safety in the Department of Justice to establish a competitive grant program that is open to public and private schools for grants to improve the safety of school buildings and to provide security training to school personnel. In administering the program, the Office of School Safety must give preference to applicants that have not yet received a school safety grant from DOJ. The bill provides $30,000,000 for these grants and specifies that the maximum amount DOJ may award to an applicant is $20,000. The bill also requires the Office of School Safety to submit an annual report related to these grants to the Joint Committee on Finance. Finally, the grant program sunsets on July 1, 2027. For further information see the state fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| SB73 | Prosecuting or adjudicating delinquent a person under the age of 18 for committing an act of prostitution. | Under current law, a person who is under the age of 18 may be prosecuted or adjudicated delinquent for committing an act of prostitution, a Class A misdemeanor. Under this bill, a person who is under the age of 18 may not be prosecuted or adjudicated delinquent for committing an act of prostitution. This bill also eliminates the option under current law in cases where a person under the age of 18 has committed an act of prostitution for a court to enter a consent decree under the Juvenile Justice Code, or a deferred prosecution agreement under the Juvenile Justice Code or adult criminal statutes, if the court determines that a consent decree or deferred prosecution agreement will serve the best interests of the person being prosecuted and will not harm society. | In Committee |
| SB176 | An income and franchise tax exemption for broadband expansion grants and for federal high-cost program funding for broadband expansion. (FE) | This bill exempts from state income and franchise taxes income received in the form of a grant issued by this state; a city, village, town, or county of this state; a tribal government in this state; or the federal government for broadband expansion in this state. The bill also exempts from income and franchise taxes income received in the form of funding from the federal government for any high-cost universal service funding for broadband expansion. Current law provides an income and franchise tax exemption for income received in the form of allocations issued by this state with moneys received from the federal coronavirus relief fund to be used for broadband expansion. The bill prohibits claiming the exemptions under the bill and the exemption under current law for the same grant. Because this bill relates to an exemption from state or local taxes, it may be referred to the Joint Survey Committee on Tax Exemptions for a report to be printed as an appendix to the bill. LRB-2503/1 KP:wlj 2025 - 2026 Legislature SENATE BILL 176 For further information see the state fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| SB272 | Eligibility for Family Care for individuals who are deaf-blind. (FE) | This bill grants functional eligibility for Family Care—a program that provides community-based long-term care services—to people who are deaf-blind. Under current law, a person must meet certain criteria in order to be eligible for Family Care, including that the person is at least 18 years of age; the person has a physical or developmental disability or is a frail elder; and the person is both functionally and financially eligible based on the standards described in the statute. The bill adds an express provision that a person is functionally eligible for the Family Care program if the person is deaf-blind, as defined in the bill. For further information see the state and local fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| SB271 | Right to bodily autonomy, elimination of certain abortion-related regulations, and coverage of abortion under certain health care coverage plans. (FE) | This bill specifies that every individual has the fundamental right to bodily autonomy, which includes the right to access abortion. Under the bill, the state may not prohibit an individual from obtaining an abortion if an abortion is necessary in the professional judgment of the individual[s medical provider. Also under the bill, a law or rule of this state that restricts a individual[s access to abortion is unenforceable if the law or rule does not confer any legitimate health benefit. Any person that is or may be aggrieved by the enforcement of a law or rule passed or LRB-2921/1 SWB&JPC:cdc 2025 - 2026 Legislature SENATE BILL 271 promulgated after the effective date of the bill that would be unenforceable under the bill may bring an action in state or federal court for injunctive relief or damages against a state or local official who enforces or attempts to enforce such a law or rule. The bill also expressly provides that all requirements applicable to health care providers are applicable to providers of abortion care. The bill does not change standard informed consent requirements applicable to all medical procedures, including abortion, but removes additional requirements specific to the performance of an abortion that exceed those standard informed consent requirements. Current law requires that these additional requirements must be met in order for a woman upon whom an abortion is to be performed or induced to give voluntary and informed consent to an abortion. Except in a medical emergency, under current law, a woman[s consent to an abortion is considered informed only if, with certain exceptions, at least 24 hours before the abortion is performed or induced, the physician or an assistant has, in person, orally provided the woman with certain information and given to the woman certain written materials. The bill repeals these requirements. Under current law, the state is required to offer to all of its employees at least 2 insured or uninsured health care coverage plans. Further, under current law, certain employers including counties, villages, towns, school districts, and other governmental units or instrumentalities other than the state may offer to all of its employees a health care coverage plan through a program offered by the Group Insurance Board. Current law prohibits these plans from providing coverage for abortion or services the funding for which is ineligible under current law. The bill repeals these restrictions and instead requires coverage of abortion and any other medical services necessary to provide abortion under these health coverage plans if the health care coverage plan provides maternity coverage. The bill also repeals other various abortion-related laws, including all of the following: 1. The bill eliminates the prohibition on giving a woman an abortion-inducing drug unless the physician who provided the drug for the woman performs a physical exam on the woman and is physically present in the room when the drug is given to the woman. 2. The bill eliminates the prohibition on coverage of abortions by qualified health plans offered through an exchange in this state. 3. The bill eliminates the prohibition on performing abortions by a physician that does not have admitting privileges in a hospital within 30 miles of the location where the abortion is to be performed. This statute was previously held to be unenforceable by the U.S. Court of Appeals for the 7th Circuit in Planned Parenthood of Wis., Inc. v. Schimel, 806 F.3d 908 (7th Cir. 2015), which affirmed a permanent injunction granted by the U.S. District Court for the Western District of Wisconsin. 4. The bill repeals a statute that provides that any person, other than the mother, who intentionally destroys the life of an unborn child may be fined not more than $10,000, imprisoned for not more than six years, or both. XUnborn childY is defined in the statute as a human being from the time of conception until born alive. LRB-2921/1 SWB&JPC:cdc 2025 - 2026 Legislature SENATE BILL 271 The statute also provides that any person, other than the mother, who intentionally destroys the life of an unborn quick child or causes the mother[s death by an act done with intent to destroy the life of an unborn child may be fined not more than $50,000, imprisoned for not more than 15 years, or both. None of these penalties apply to a therapeutic abortion that is performed by a physician; is necessary, or advised by two other physicians as necessary, to save the life of the mother; and, unless an emergency prevents, is performed in a licensed maternity hospital. This statute was previously held to be unenforceable. It was cited in Roe v. Wade, 410 U.S. 113 (1973), as similar to a Texas statute that was held to violate the due process clause of the 14th Amendment to the U.S. Constitution. The unenforceability of the statute following the Roe v. Wade decision was noted in a subsequent decision by a federal district court, Larkin v. McCann, 368 F. Supp. 1352 (E.D. Wis. 1974). In June 2022, the U.S. Supreme Court overturned the Roe v. Wade decision in Dobbs v. Jackson Women[s Health Org., 142 S. Ct. 2228 (2022). Litigation concerning the status of the statute is currently pending in state court. In December 2023, the Dane County Circuit Court issued a decision and order declaring that the statute Xdoes not apply to abortions.Y Kaul v. Urmanski, No. 22- CV-1594, slip op. at 14 (Wis. Dane Cnty. Cir. Ct. Dec. 5, 2023). An appeal is pending before the Wisconsin Supreme Court. See Kaul v. Urmanski, No. 2023AP002362 (Wis. July 2, 2024) (order granting a petition to bypass the court of appeals). The Wisconsin Supreme Court has also granted a petition for leave to commence an original action regarding whether the state constitution protects a right to receive an abortion and a right for physicians to provide abortions. See Planned Parenthood of Wisconsin v. Urmanski, No. 2024AP000330 (Wis. July 2, 2024) (order granting leave to commence an original action); see Petition to Wis. S. Ct. to Take Jurisdiction of an Original Action, Planned Parenthood of Wisconsin v. Urmanski, No. 2024AP000330 (Wis. filed Feb. 22, 2024). The bill also repeals the criminal penalty on a person who is not a physician and who intentionally performs an abortion. The bill does not affect any other criminal prohibition or limitation on abortion in current law, such as the general prohibition on performing an abortion after the fetus or unborn child has reached viability, or any other homicide prohibition. The bill also does not affect a separate provision in current law that prohibits prosecution of and imposing or enforcing a fine or imprisonment against a woman who obtains an abortion or otherwise violates any abortion law with respect to her unborn child or fetus. For further information see the state and local fiscal estimate, which will be printed as an appendix to this bill. This proposal may contain a health insurance mandate requiring a social and financial impact report under s. 601.423, stats. | In Committee |
| AB246 | Cost-sharing caps on prescription drugs and medical supplies to treat asthma under health insurance policies and plans. (FE) | This bill requires health insurance policies and plans that provide coverage of prescription drugs to cover prescription drugs and related medical supplies for the treatment of asthma. This bill provides that Xrelated medical suppliesY includes asthma inhalers and other medical supply items necessary to effectively and appropriately administer a prescription drug prescribed to treat asthma. This bill requires policies and plans to limit the amount of any enrollee cost-sharing for the coverage provided in the bill to no more than $25 per one-month supply for each prescription drug prescribed to treat asthma and to no more than $50 per month for all related medical supplies. Cost-sharing may not increase with the number of conditions for which an enrollee is treated. Further, the coverage provided in the bill may not be subject to any deductible. However, the bill provides that the limitations on cost-sharing and deductibles do not apply to the extent that the limitations would result in ineligibility for a health savings account under the federal Internal Revenue Code. This proposal may contain a health insurance mandate requiring a social and financial impact report under s. 601.423, stats. For further information see the state fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| SB251 | Cost-sharing caps on prescription drugs and medical supplies to treat asthma under health insurance policies and plans. (FE) | This bill requires health insurance policies and plans that provide coverage of prescription drugs to cover prescription drugs and related medical supplies for the treatment of asthma. This bill provides that Xrelated medical suppliesY includes asthma inhalers and other medical supply items necessary to effectively and appropriately administer a prescription drug prescribed to treat asthma. This bill requires policies and plans to limit the amount of any enrollee cost-sharing for the coverage provided in the bill to no more than $25 per one-month supply for each prescription drug prescribed to treat asthma and to no more than $50 per month for all related medical supplies. Cost-sharing may not increase with the number of conditions for which an enrollee is treated. Further, the coverage provided in the bill may not be subject to any deductible. However, the bill provides that the limitations on cost-sharing and deductibles do not apply to the extent that the limitations would result in ineligibility for a health savings account under the federal Internal Revenue Code. This proposal may contain a health insurance mandate requiring a social and financial impact report under s. 601.423, stats. LRB-2917/1 JPC:cjs&skw 2025 - 2026 Legislature SENATE BILL 251 For further information see the state fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| SJR55 | Recognizing the United States Army’s 250th birthday. | Relating to: recognizing the United States Army[s 250th birthday. | In Committee |
| SJR56 | Proclaiming April 20 to 26 as 2025 National Infertility Awareness Week in Wisconsin. | Relating to: proclaiming April 20 to 26 as 2025 National Infertility Awareness Week in Wisconsin. | In Committee |
| AJR18 | Honoring the life and public service of Representative Jonathan Brostoff. | Relating to: honoring the life and public service of Representative Jonathan Brostoff. | Signed/Enacted/Adopted |
| AB272 | Eligibility for Family Care for individuals who are deaf-blind. (FE) | This bill grants functional eligibility for Family Care—a program that provides community-based long-term care services—to people who are deaf-blind. Under current law, a person must meet certain criteria in order to be eligible for Family Care, including that the person is at least 18 years of age; the person has a physical or developmental disability or is a frail elder; and the person is both functionally and financially eligible based on the standards described in the statute. The bill adds an express provision that a person is functionally eligible for the Family Care program if the person is deaf-blind, as defined in the bill. For further information see the state and local fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| AJR55 | Designating May as Mental Health Awareness Month in Wisconsin. | Relating to: designating May as Mental Health Awareness Month in Wisconsin. | Signed/Enacted/Adopted |
| AJR35 | Proclaiming May 16, 17, and 18, 2025, Syttende Mai Weekend. | Relating to: proclaiming May 16, 17, and 18, 2025, Syttende Mai Weekend. | Signed/Enacted/Adopted |
| SB99 | Spinal cord injury research grants and symposia and making an appropriation. (FE) | This bill requires the Department of Health Services to establish a program to award grants to persons in this state for research into spinal cord injuries. The grants must support research into new and innovative treatments and rehabilitative efforts for the functional improvement of individuals with spinal cord injuries. Research topics may include pharmaceutical, medical device, brain stimulus, and rehabilitative approaches and techniques. DHS must make annual reports to the legislature about the grants. The bill specifies that no more than 8 percent of any grant award may be used for administrative or indirect costs and expenses. The bill also requires DHS to appoint a Spinal Cord Injury Council with one member representing the University of Wisconsin School of Medicine and Public Health who is a researcher specializing in spinal cord injuries, one member representing Marquette University who is a researcher specializing in spinal cord injuries, one member representing the Medical College of Wisconsin who is an expert in spinal cord injuries, and the following members: 1) a person with a spinal cord injury; 2) a family member of a person with a spinal cord injury; 3) a veteran LRB-2084/1 JPC:skw 2025 - 2026 Legislature SENATE BILL 99 with a spinal cord injury; 4) a physician specializing in the treatment of spinal cord injuries; 5) a neurosurgery researcher; and 6) a researcher employed by the federal Veterans Health Administration of the U.S. Department of Veterans Affairs. If DHS is unable to appoint any of the foregoing members, the bill allows DHS to appoint, in lieu of that member, a member representing the general public. Members of the council have two-year terms. The bill requires the council to develop criteria for DHS to evaluate and award grants, review and make recommendations on grant applications, and perform other duties specified by DHS. Council members must make written disclosures of financial interests in organizations that the council recommends for grants. Finally, the bill allows DHS, with the permission of the council, to hold symposia, not more than once every two years, for grant recipients to present findings of research supported by the grants. For further information see the state fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| SJR35 | Proclaiming May 16, 17, and 18, 2025, Syttende Mai Weekend. | Relating to: proclaiming May 16, 17, and 18, 2025, Syttende Mai Weekend. | In Committee |
| AJR40 | Celebrating 50 years of strength and resilience of the Hmong, Lao, Cambodian, and Vietnamese people. | Relating to: celebrating 50 years of strength and resilience of the Hmong, Lao, Cambodian, and Vietnamese people. | Crossed Over |
| AJR37 | Declaring May 2025 as Ehlers-Danlos Syndromes and Hypermobility Spectrum Disorders Awareness Month. | Relating to: declaring May 2025 as Ehlers-Danlos Syndromes and Hypermobility Spectrum Disorders Awareness Month. | Crossed Over |
| SJR53 | Designating May as Mental Health Awareness Month in Wisconsin. | Relating to: designating May as Mental Health Awareness Month in Wisconsin. | In Committee |
| AB137 | Maximum life and allocation period for Tax Incremental District Number 9 in the village of DeForest and the total value of taxable property that may be included in tax incremental financing districts created in the village of DeForest. (FE) | AN ACT to create 66.1105 (6) (a) 22., 66.1105 (6) (g) 7., 66.1105 (7) (am) 10. and 66.1105 (17) (h) of the statutes; relating to: maximum life and allocation period for Tax Incremental District Number 9 in the village of DeForest and the total value of taxable property that may be included in tax incremental financing districts created in the village of DeForest. This bill creates exceptions to two aspects of the statutes governing tax incremental financing (TIF) for a tax incremental district (TIDs) located in the village of DeForest. Under current law, cities and villages may use TIF to encourage development in the city or village. In general, under TIF, a city or village pays for improvements in a TID and then collects tax moneys attributable to all taxing jurisdictions on the increased property value in the TID for a certain period of time to pay for the improvements. Ideally, after the period of time, the city or village will have been repaid for its initial investment and the property tax base in the TID will have permanently increased in value. In general and in brief, a city or village makes use of TIF using the following procedure: 1. The city or village designates an area as a TID and creates a project plan laying out the expenditures that the city or village will make within the TID. 2. DOR establishes the Xbase valueY of the TID. This value is the equalized value of all taxable property within the TID at the time of its creation. 3. Each year thereafter, the Xvalue incrementY of the property within the TID is determined by subtracting the base value from the current value of property within the TID. The portion of taxes collected on any positive value increment (Xtax incrementY) is collected by the city or village for use solely for the project costs of the TID. The tax increment includes the taxes that would have been collected by other taxing jurisdictions, such as counties or school districts, were the TID not created. 4. Tax increments are collected until the city or village has recovered all of the TID[s project costs or until the TID reaches its statutory termination date. TID Number 9 in the village of DeForest was created as a mixed-use TID in September 2017. Under current law, the unextended termination date of TID Number 9 in the village of DeForest is 20 years. Under this bill, the life of TID Number 9 in the village of DeForest is extended, and tax increments may continue to be allocated, for up to 30 years after the TID[s creation. Under current law, the equalized value of taxable property of a new or amended TID plus the value increment of all existing TIDs in a city or village may not exceed 12 percent of the total equalized value of taxable property in the city or village. Under the bill, the 12 percent rule does not apply to one amendment of the project plan of TID Number 9 in the village of DeForest. Also under current law, a city or village may extend the life of a TID for up to one year for housing stock improvement if all of the following occur: 1. The city or village pays off all of the TID[s project costs. 2. The city or village adopts a resolution stating that it intends to extend the life of the TID, the number of months it intends to do so, and how it intends to improve housing stock. 3. The city or village notifies DOR. Under the bill, a housing stock improvement extension may not be exercised with regard to TID Number 9 in the village of DeForest. For further information see the state and local fiscal estimate, which will be printed as an appendix to this bill. | Crossed Over |
| SB14 | Pelvic exams on unconscious patients and creating an administrative rule related to hospital requirements for pelvic exams on unconscious patients. | This bill requires hospitals to ensure written informed consent is obtained from a patient before a pelvic exam is performed solely for educational purposes on the patient while the patient is under general anesthesia or otherwise unconscious. The bill also creates a Department of Health Services rule providing that hospitals must maintain written policies and procedures requiring written informed consent to be obtained from a patient before a pelvic exam is performed solely for educational purposes on the patient while the patient is under general anesthesia or otherwise unconscious. | Passed |
| AB11 | Pelvic exams on unconscious patients and creating an administrative rule related to hospital requirements for pelvic exams on unconscious patients. | This bill requires hospitals to ensure written informed consent is obtained from a patient before a pelvic exam is performed solely for educational purposes on the patient while the patient is under general anesthesia or otherwise unconscious. The bill also creates a Department of Health Services rule providing that hospitals must maintain written policies and procedures requiring written informed consent to be obtained from a patient before a pelvic exam is performed solely for educational purposes on the patient while the patient is under general anesthesia or otherwise unconscious. | In Committee |
| SB133 | Maximum life and allocation period for Tax Incremental District Number 9 in the village of DeForest and the total value of taxable property that may be included in tax incremental financing districts created in the village of DeForest. (FE) | AN ACT to create 66.1105 (6) (a) 22., 66.1105 (6) (g) 7., 66.1105 (7) (am) 10. and 66.1105 (17) (h) of the statutes; relating to: maximum life and allocation period for Tax Incremental District Number 9 in the village of DeForest and the total value of taxable property that may be included in tax incremental financing districts created in the village of DeForest. This bill creates exceptions to two aspects of the statutes governing tax incremental financing (TIF) for a tax incremental district (TIDs) located in the village of DeForest. Under current law, cities and villages may use TIF to encourage development in the city or village. In general, under TIF, a city or village pays for improvements in a TID and then collects tax moneys attributable to all taxing jurisdictions on the increased property value in the TID for a certain period of time to pay for the improvements. Ideally, after the period of time, the city or village will have been repaid for its initial investment and the property tax base in the TID will have permanently increased in value. In general and in brief, a city or village makes use of TIF using the following procedure: 1. The city or village designates an area as a TID and creates a project plan laying out the expenditures that the city or village will make within the TID. LRB-2363/1 EVM:cdc 2025 - 2026 Legislature SENATE BILL 133 2. DOR establishes the Xbase valueY of the TID. This value is the equalized value of all taxable property within the TID at the time of its creation. 3. Each year thereafter, the Xvalue incrementY of the property within the TID is determined by subtracting the base value from the current value of property within the TID. The portion of taxes collected on any positive value increment (Xtax incrementY) is collected by the city or village for use solely for the project costs of the TID. The tax increment includes the taxes that would have been collected by other taxing jurisdictions, such as counties or school districts, were the TID not created. 4. Tax increments are collected until the city or village has recovered all of the TID[s project costs or until the TID reaches its statutory termination date. TID Number 9 in the village of DeForest was created as a mixed-use TID in September 2017. Under current law, the unextended termination date of TID Number 9 in the village of DeForest is 20 years. Under this bill, the life of TID Number 9 in the village of DeForest is extended, and tax increments may continue to be allocated, for up to 30 years after the TID[s creation. Under current law, the equalized value of taxable property of a new or amended TID plus the value increment of all existing TIDs in a city or village may not exceed 12 percent of the total equalized value of taxable property in the city or village. Under the bill, the 12 percent rule does not apply to one amendment of the project plan of TID Number 9 in the village of DeForest. Also under current law, a city or village may extend the life of a TID for up to one year for housing stock improvement if all of the following occur: 1. The city or village pays off all of the TID[s project costs. 2. The city or village adopts a resolution stating that it intends to extend the life of the TID, the number of months it intends to do so, and how it intends to improve housing stock. 3. The city or village notifies DOR. Under the bill, a housing stock improvement extension may not be exercised with regard to TID Number 9 in the village of DeForest. For further information see the state and local fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| SB168 | Changing the conditions of liability for worker’s compensation benefits for emergency medical responders, emergency medical services practitioners, volunteer firefighters, correctional officers, emergency dispatchers, coroners and coroner staff, and medical examiners and medical examiner staff. (FE) | This bill makes changes to the conditions of liability for worker[s compensation benefits for emergency medical responders, emergency medical services practitioners, volunteer firefighters, correctional officers, emergency dispatchers, coroners and coroner staff members, and medical examiners and medical examiner staff members who are diagnosed with post-traumatic stress disorder (PTSD). Under current law, if a law enforcement officer or full-time firefighter is diagnosed with PTSD by a licensed psychiatrist or psychologist, and the mental injury that resulted in that diagnosis is not accompanied by a physical injury, that LRB-0062/1 MIM:amn 2025 - 2026 Legislature SENATE BILL 168 law enforcement officer or firefighter can bring a claim for worker[s compensation benefits if the conditions of liability are proven by the preponderance of the evidence and the mental injury is not the result of a good faith employment action by the person[s employer. Also under current law, liability for such treatment for a mental injury is limited to no more than 32 weeks after the injury is first reported. Under current law, an injured emergency medical responder, emergency medical services practitioner, volunteer firefighter, correctional officer, emergency dispatcher, coroner, coroner staff member, medical examiner, or medical examiner staff member who does not have an accompanying physical injury must demonstrate a diagnosis based on unusual stress of greater dimensions than the day-to-day emotional strain and tension experienced by all employees as required under School District No. 1 v. DILHR, 62 Wis. 2d 370, 215 N.W.2d 373 (1974) in order to receive worker[s compensation benefits for PTSD. Under the bill, such an injured emergency medical responder, emergency medical services practitioner, volunteer firefighter, correctional officer, emergency dispatcher, coroner, coroner staff member, medical examiner, or medical examiner staff member is not required to demonstrate a diagnosis based on that standard, and instead must demonstrate a diagnosis based on the same standard as law enforcement officers and firefighters. Finally, under the bill, an emergency medical responder, emergency medical services practitioner, volunteer firefighter, correctional officer, emergency dispatcher, coroner, coroner staff member, medical examiner, or medical examiner staff member is restricted to compensation for a mental injury that is not accompanied by a physical injury and that results in a diagnosis of PTSD three times in his or her lifetime irrespective of a change of employer or employment in the same manner as law enforcement officers and firefighters. For further information see the state and local fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| AB208 | An income and franchise tax exemption for broadband expansion grants and for federal high-cost program funding for broadband expansion. (FE) | This bill exempts from state income and franchise taxes income received in the form of a grant issued by this state; a city, village, town, or county of this state; a tribal government in this state; or the federal government for broadband expansion in this state. The bill also exempts from income and franchise taxes income received in the form of funding from the federal government for any high-cost universal service funding for broadband expansion. Current law provides an income and franchise tax exemption for income received in the form of allocations issued by this state with moneys received from the federal coronavirus relief fund to be used for broadband expansion. The bill prohibits claiming the exemptions under the bill and the exemption under current law for the same grant. Because this bill relates to an exemption from state or local taxes, it may be referred to the Joint Survey Committee on Tax Exemptions for a report to be printed as an appendix to the bill. For further information see the state fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| AB220 | Discrimination in employment, housing, public accommodations, education, insurance coverage, national guard, jury duty, and adoption and in the receipt of mental health or vocational rehabilitation services. | This bill prohibits discrimination on the basis of an individual[s gender identity or gender expression. The bill defines Xgender identityY as an individual[s internal, deeply held knowledge or sense of their own gender, regardless of the individual[s sex assigned at birth or gender identifiers on official governmental documents, and Xgender expressionY as an individual[s gender-related appearance or behavior, or the perception of that appearance or behavior, regardless of whether it is stereotypically associated with the individual[s sex assigned at birth. The bill also make changes to various discrimination laws, including all of the following: 1. Current law prohibits discrimination in employment, housing, and the equal enjoyment of a public place of accommodation or amusement on the basis of a person[s sex or sexual orientation. Current law also requires certain state agencies, authorities, and corporations to include provisions in contracts they execute obliging the contractor to similarly not discriminate against any employee or applicant for employment. The bill adds gender identity and gender expression as prohibited bases for discrimination in these areas. 2. Current law prohibits the University of Wisconsin System, the Technical College System, public elementary and secondary schools, and charter schools from discriminating against a student on the basis of the student[s sex or sexual orientation. The bill prohibits the same educational institutions from discriminating against a student on the basis of the student[s gender identity or gender expression and from discriminating against a student based on the protected status of the student[s parent. The bill also prohibits the UW System Board of Regents from investing gifts, grants, and bequests in companies that practice discrimination based on sexual orientation, gender identity, or gender expression. 3. Current law prohibits the exclusion of an individual from jury duty on the basis of the individual[s sex or sexual orientation. The bill adds gender identity and gender expression as a prohibited bases for exclusion of an individual from jury duty. 4. Current law allows only either a single adult or a husband and wife jointly to adopt a child. The bill allows only either a single individual or two individuals married to each other jointly to adopt a child and also provides that no otherwise qualified person may be denied the benefits of the adoption and guardianship statute subchapter because of the person[s sex, sexual orientation, gender identity, or gender expression. 5. Current law requires heads of executive departments and agencies to determine whether there is arbitrary discrimination on the basis of sex or sexual orientation and to take remedial action if such discrimination is found. The bill requires these heads to also determine if there is discrimination on the basis of gender identity or gender expression and to take remedial action regarding such discrimination. 6. Current law prohibits discriminating against an employee, prospective employee, patient, or resident of an approved treatment facility providing treatment of alcoholic, drug dependent, mentally ill, or developmentally disabled persons on the basis of sex. The bill adds sexual orientation, gender identity, and gender expression as prohibited bases of discrimination. 7. Current law prohibits agency rules from discriminating against a person by reason of sex or sexual orientation. The bill adds gender identity and gender expression as prohibited bases of discrimination. 8. Current law prohibits discrimination on the basis of sex in the provision of vocational rehabilitation or mental health services. The bill adds sexual orientation, gender identity, and gender expression as prohibited bases of discrimination. 9. Current law prohibits the national guard or state defense force from denying membership based on sex or sexual orientation. The bill adds gender identity and gender expression as prohibited bases of discrimination. The bill also provides that no member of the national guard or state defense force may be denied equal access to facilities most consistent with the person[s gender identity. 10. Current law provides that sex is a bona fide occupational qualification if all of the members of one sex are physically incapable of performing the essential duties required by a job or if the essence of the employer[s business operation would be undermined if employees were not hired exclusively from one sex. The bill adds to the sex as a bona fide occupational qualification law that an individual may not be treated or regarded inconsistent with the individual[s gender identity or discriminated against based on the individual[s gender identity or gender expression. 11. Current law allows public places of accommodation or amusement to provide separate facilities to persons of different sexes. The bill provides that public places of accommodation or amusement may provide separate facilities to persons of different sexes but prohibits those places from denying individuals equal access to the facilities most consistent with the individual[s gender identity. 12. The bill prohibits an insurer from discriminating against an individual on the basis of age, residence, race, color, creed, religion, national origin, ancestry, marital status, occupation, gender identity, gender expression, sex, or sexual orientation, and also prohibits motor carriers, automobile insurers, transportation network companies, and real estate brokers and salespersons from discriminating against an individual on the basis of sexual orientation, gender identity, or gender expression. 13. The bill expressly prohibits a school board from discriminating against a student-led organization because the organization[s mission is related to sexual orientation, gender identity, or gender expression. For further information see the state and local fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| AB158 | Changing the conditions of liability for worker’s compensation benefits for emergency medical responders, emergency medical services practitioners, volunteer firefighters, correctional officers, emergency dispatchers, coroners and coroner staff, and medical examiners and medical examiner staff. (FE) | This bill makes changes to the conditions of liability for worker[s compensation benefits for emergency medical responders, emergency medical services practitioners, volunteer firefighters, correctional officers, emergency dispatchers, coroners and coroner staff members, and medical examiners and medical examiner staff members who are diagnosed with post-traumatic stress disorder (PTSD). Under current law, if a law enforcement officer or full-time firefighter is diagnosed with PTSD by a licensed psychiatrist or psychologist, and the mental injury that resulted in that diagnosis is not accompanied by a physical injury, that law enforcement officer or firefighter can bring a claim for worker[s compensation benefits if the conditions of liability are proven by the preponderance of the evidence and the mental injury is not the result of a good faith employment action by the person[s employer. Also under current law, liability for such treatment for a mental injury is limited to no more than 32 weeks after the injury is first reported. Under current law, an injured emergency medical responder, emergency medical services practitioner, volunteer firefighter, correctional officer, emergency dispatcher, coroner, coroner staff member, medical examiner, or medical examiner staff member who does not have an accompanying physical injury must demonstrate a diagnosis based on unusual stress of greater dimensions than the day-to-day emotional strain and tension experienced by all employees as required under School District No. 1 v. DILHR, 62 Wis. 2d 370, 215 N.W.2d 373 (1974) in order to receive worker[s compensation benefits for PTSD. Under the bill, such an injured emergency medical responder, emergency medical services practitioner, volunteer firefighter, correctional officer, emergency dispatcher, coroner, coroner staff member, medical examiner, or medical examiner staff member is not required to demonstrate a diagnosis based on that standard, and instead must demonstrate a diagnosis based on the same standard as law enforcement officers and firefighters. Finally, under the bill, an emergency medical responder, emergency medical services practitioner, volunteer firefighter, correctional officer, emergency dispatcher, coroner, coroner staff member, medical examiner, or medical examiner staff member is restricted to compensation for a mental injury that is not accompanied by a physical injury and that results in a diagnosis of PTSD three times in his or her lifetime irrespective of a change of employer or employment in the same manner as law enforcement officers and firefighters. Because this bill relates to public employee retirement or pensions, it may be referred to the Joint Survey Committee on Retirement Systems for a report to be printed as an appendix to the bill. For further information see the state and local fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| AJR50 | Recognizing the United States Army’s 250th birthday. | Relating to: recognizing the United States Army[s 250th birthday. | In Committee |
| SJR47 | Observing Tuesday, March 25, 2025, as Equal Pay Day in Wisconsin. | Relating to: observing Tuesday, March 25, 2025, as Equal Pay Day in Wisconsin. | In Committee |
| SB178 | Changes to the low-income housing tax credit. (FE) | Under current law, the Wisconsin Housing and Economic Development Authority administers a low-income housing tax credit program. Under that program, a person may claim as a credit against the person[s income or franchise tax liability, or against the person[s liability for fees imposed on an insurer, the amount allocated by WHEDA in an Xallocation certificateY for a qualified low- income housing project. The bill also requires that WHEDA, if possible, ensure that at least 35 percent of the tax credits it allocates each year under the program are for qualified low- income housing projects in rural areas in Wisconsin and removes the requirement that a qualified low-income housing project be financed with tax-exempt bonds. Finally, the bill makes a technical change to the credit for insurers so that an LRB-2483/1 JK&MDE:cdc 2025 - 2026 Legislature SENATE BILL 178 insurer who is a shareholder of a tax-option corporation, a partner of a partnership, or a member of a limited liability company may claim the credit. For further information see the state fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| AJR52 | Proclaiming April 20 to 26 as 2025 National Infertility Awareness Week in Wisconsin. | Relating to: proclaiming April 20 to 26 as 2025 National Infertility Awareness Week in Wisconsin. | In Committee |
| AJR54 | Observing Tuesday, March 25, 2025, as Equal Pay Day in Wisconsin. | Relating to: observing Tuesday, March 25, 2025, as Equal Pay Day in Wisconsin. | In Committee |
| AB155 | Designating the Tom Diehl Memorial Highway. (FE) | This bill directs the Department of Transportation to designate and mark USH 12 in the village of Lake Delton in Sauk County as the XTom Diehl Memorial Highway.Y For further information see the state fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| AB182 | Changes to the low-income housing tax credit. (FE) | Under current law, the Wisconsin Housing and Economic Development Authority administers a low-income housing tax credit program. Under that program, a person may claim as a credit against the person[s income or franchise tax liability, or against the person[s liability for fees imposed on an insurer, the amount allocated by WHEDA in an Xallocation certificateY for a qualified low- income housing project. The bill also requires that WHEDA, if possible, ensure that at least 35 percent of the tax credits it allocates each year under the program are for qualified low- income housing projects in rural areas in Wisconsin and removes the requirement that a qualified low-income housing project be financed with tax-exempt bonds. Finally, the bill makes a technical change to the credit for insurers so that an insurer who is a shareholder of a tax-option corporation, a partner of a partnership, or a member of a limited liability company may claim the credit. For further information see the state fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| SB113 | A transition to grazing pilot program and making an appropriation. (FE) | This bill creates a Xtransition to grazing pilot programY in the Department of Agriculture, Trade and Consumer Protection to provide support and grants to farmers who are implementing livestock forage-based managed grazing systems and farmers and agribusinesses in the grazing-fed livestock business. Under the bill the department may award up to $40,000 to each grantee, and may disperse up to 75 percent of the grant in the first year following the department[s decision to grant the award and may disperse up to 12.5 percent of the award in each of the second and third years following the department[s decision to grant the award. For further information see the state fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| AB118 | A transition to grazing pilot program and making an appropriation. (FE) | This bill creates a Xtransition to grazing pilot programY in the Department of Agriculture, Trade and Consumer Protection to provide support and grants to farmers who are implementing livestock forage-based managed grazing systems and farmers and agribusinesses in the grazing-fed livestock business. Under the bill the department may award up to $40,000 to each grantee, and may disperse up to 75 percent of the grant in the first year following the department[s decision to grant the award and may disperse up to 12.5 percent of the award in each of the second and third years following the department[s decision to grant the award. For further information see the state fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| AJR36 | The right of the people to a clean, safe, and healthy natural environment and to its preservation (first consideration). | relating to: the right of the people to a clean, safe, and healthy natural environment and to its preservation (first consideration). | In Committee |
| AJR42 | An advisory referendum on an amendment to the U.S. Constitution. | Relating to: an advisory referendum on an amendment to the U.S. Constitution. | In Committee |
| SJR41 | Celebrating 50 years of strength and resilience of the Hmong, Lao, Cambodian, and Vietnamese people. | Relating to: celebrating 50 years of strength and resilience of the Hmong, Lao, Cambodian, and Vietnamese people. | In Committee |
| SB160 | Designating the Tom Diehl Memorial Highway. (FE) | This bill directs the Department of Transportation to designate and mark USH 12 in the village of Lake Delton in Sauk County as the XTom Diehl Memorial Highway.Y For further information see the state fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| AB177 | Sales and use tax exemption for diapers and feminine hygiene products. (FE) | This bill creates a sales and use tax exemption for the sale of diapers and feminine hygiene products. Because this bill relates to an exemption from state or local taxes, it may be referred to the Joint Survey Committee on Tax Exemptions for a report to be printed as an appendix to the bill. For further information see the state and local fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| SB195 | Serving maple syrup in a public eating place. | Under this bill, a public eating place may not serve a food product identified as maple syrup unless the product is made entirely of maple syrup, as the term is defined in federal regulations. | In Committee |
| AJR34 | Honoring the 50th anniversary of the child support program. | Relating to: honoring the 50th anniversary of the child support program. | In Committee |
| AB205 | Serving maple syrup in a public eating place. | Under this bill, a public eating place may not serve a food product identified as maple syrup unless the product is made entirely of maple syrup, as the term is defined in federal regulations. | In Committee |
| AB120 | Positions for the Office of School Safety. (FE) | Under current law, there is an Office of School Safety in the Department of Justice. The office has 14.2 project positions that will expire on October 1, 2025; the purpose of these positions is to support and enhance school safety initiatives. Under current law, the positions are funded by fees that DOJ receives for performing background checks for handgun sales and for issuing licenses to carry a concealed weapon. This bill creates the positions as permanent positions and funds them with general purpose revenue beginning on October 1, 2025, when the project positions expire. For further information see the state fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| SB114 | Sales and use tax exemption for diapers and feminine hygiene products. (FE) | This bill creates a sales and use tax exemption for the sale of diapers and feminine hygiene products. Because this bill relates to an exemption from state or local taxes, it may be referred to the Joint Survey Committee on Tax Exemptions for a report to be printed as an appendix to the bill. For further information see the state and local fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| SB119 | Positions for the Office of School Safety. (FE) | Under current law, there is an Office of School Safety in the Department of Justice. The office has 14.2 project positions that will expire on October 1, 2025; the purpose of these positions is to support and enhance school safety initiatives. Under current law, the positions are funded by fees that DOJ receives for performing background checks for handgun sales and for issuing licenses to carry a concealed weapon. This bill creates the positions as permanent positions and funds them with general purpose revenue beginning on October 1, 2025, when the project positions expire. For further information see the state fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| SJR34 | Honoring the 50th anniversary of the child support program. | Relating to: honoring the 50th anniversary of the child support program. | In Committee |
| SJR38 | An advisory referendum on an amendment to the U.S. Constitution. | Relating to: an advisory referendum on an amendment to the U.S. Constitution. | In Committee |
| SJR39 | Declaring May 2025 as Ehlers-Danlos Syndromes and Hypermobility Spectrum Disorders Awareness Month. | Relating to: declaring May 2025 as Ehlers-Danlos Syndromes and Hypermobility Spectrum Disorders Awareness Month. | In Committee |
| SJR37 | The right of the people to a clean, safe, and healthy natural environment and to its preservation (first consideration). | relating to: the right of the people to a clean, safe, and healthy natural environment and to its preservation (first consideration). | In Committee |
| SB233 | Inducements to sign or refrain from signing nomination papers, recall petitions, and certain other petitions. | Current law prohibits certain kinds of election bribery, including offering, giving, lending, or providing money or anything of value to an elector or other person to induce the elector to vote or refrain from voting. Under current law, Xanything of valueY includes an object having utility independent of a political message it contains, the value of which exceeds $1. Election bribery is a Class I felony, the penalty for which is a fine not to exceed $10,000 or imprisonment not to exceed three years and six months, or both. This bill prohibits as election bribery such inducement of an elector to sign or refrain from signing a petition supporting or opposing a candidate, referendum, or proposition about political or social issues, state law, or proposed or potential legislation, if the petition is related to an election or referendum or is circulated during an election period, as defined in the bill. Additionally, the bill prohibits as election bribery such inducement of an elector to sign or refrain from signing nomination papers or a recall petition. Finally, the bill defines Xanything of valueY for purposes of a violation of the LRB-2797/1 MPG:emw&skw 2025 - 2026 Legislature SENATE BILL 233 bill[s provisions to include an object having utility independent of a political message it contains, if the object[s value exceeds $5, rather than 1$. | In Committee |
| SB208 | Prohibiting hedge funds from acquiring single-family homes in this state. (FE) | This bill prohibits a hedge fund from acquiring a single-family home in this state. The bill provides that an ownership interest in a single-family home acquired or owned by a hedge fund in violation of the bill is forfeited to the state and that the attorney general is responsible for enforcement. For further information see the state fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| AB213 | Prohibiting hedge funds from acquiring single-family homes in this state. (FE) | This bill prohibits a hedge fund from acquiring a single-family home in this state. The bill provides that an ownership interest in a single-family home acquired or owned by a hedge fund in violation of the bill is forfeited to the state and that the attorney general is responsible for enforcement. For further information see the state fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| SB223 | Discrimination in employment, housing, public accommodations, education, insurance coverage, national guard, jury duty, and adoption and in the receipt of mental health or vocational rehabilitation services. | This bill prohibits discrimination on the basis of an individual[s gender identity or gender expression. The bill defines Xgender identityY as an individual[s internal, deeply held knowledge or sense of their own gender, regardless of the individual[s sex assigned at birth or gender identifiers on official governmental documents, and Xgender expressionY as an individual[s gender-related appearance or behavior, or the perception of that appearance or behavior, regardless of whether it is stereotypically associated with the individual[s sex assigned at birth. The bill also make changes to various discrimination laws, including all of the following: 1. Current law prohibits discrimination in employment, housing, and the equal enjoyment of a public place of accommodation or amusement on the basis of a person[s sex or sexual orientation. Current law also requires certain state agencies, authorities, and corporations to include provisions in contracts they execute obliging the contractor to similarly not discriminate against any employee or applicant for employment. The bill adds gender identity and gender expression as prohibited bases for discrimination in these areas. 2. Current law prohibits the University of Wisconsin System, the Technical College System, public elementary and secondary schools, and charter schools from discriminating against a student on the basis of the student[s sex or sexual orientation. The bill prohibits the same educational institutions from discriminating against a student on the basis of the student[s gender identity or gender expression and from discriminating against a student based on the protected status of the student[s parent. The bill also prohibits the UW System Board of Regents from investing gifts, grants, and bequests in companies that practice discrimination based on sexual orientation, gender identity, or gender expression. 3. Current law prohibits the exclusion of an individual from jury duty on the basis of the individual[s sex or sexual orientation. The bill adds gender identity and gender expression as a prohibited bases for exclusion of an individual from jury duty. 4. Current law allows only either a single adult or a husband and wife jointly to adopt a child. The bill allows only either a single individual or two individuals married to each other jointly to adopt a child and also provides that no otherwise qualified person may be denied the benefits of the adoption and guardianship LRB-0820/1 MIM&FFK:emw 2025 - 2026 Legislature SENATE BILL 223 statute subchapter because of the person[s sex, sexual orientation, gender identity, or gender expression. 5. Current law requires heads of executive departments and agencies to determine whether there is arbitrary discrimination on the basis of sex or sexual orientation and to take remedial action if such discrimination is found. The bill requires these heads to also determine if there is discrimination on the basis of gender identity or gender expression and to take remedial action regarding such discrimination. 6. Current law prohibits discriminating against an employee, prospective employee, patient, or resident of an approved treatment facility providing treatment of alcoholic, drug dependent, mentally ill, or developmentally disabled persons on the basis of sex. The bill adds sexual orientation, gender identity, and gender expression as prohibited bases of discrimination. 7. Current law prohibits agency rules from discriminating against a person by reason of sex or sexual orientation. The bill adds gender identity and gender expression as prohibited bases of discrimination. 8. Current law prohibits discrimination on the basis of sex in the provision of vocational rehabilitation or mental health services. The bill adds sexual orientation, gender identity, and gender expression as prohibited bases of discrimination. 9. Current law prohibits the national guard or state defense force from denying membership based on sex or sexual orientation. The bill adds gender identity and gender expression as prohibited bases of discrimination. The bill also provides that no member of the national guard or state defense force may be denied equal access to facilities most consistent with the person[s gender identity. 10. Current law provides that sex is a bona fide occupational qualification if all of the members of one sex are physically incapable of performing the essential duties required by a job or if the essence of the employer[s business operation would be undermined if employees were not hired exclusively from one sex. The bill adds to the sex as a bona fide occupational qualification law that an individual may not be treated or regarded inconsistent with the individual[s gender identity or discriminated against based on the individual[s gender identity or gender expression. 11. Current law allows public places of accommodation or amusement to provide separate facilities to persons of different sexes. The bill provides that public places of accommodation or amusement may provide separate facilities to persons of different sexes but prohibits those places from denying individuals equal access to the facilities most consistent with the individual[s gender identity. 12. The bill prohibits an insurer from discriminating against an individual on the basis of age, residence, race, color, creed, religion, national origin, ancestry, marital status, occupation, gender identity, gender expression, sex, or sexual orientation, and also prohibits motor carriers, automobile insurers, transportation network companies, and real estate brokers and salespersons from discriminating LRB-0820/1 MIM&FFK:emw 2025 - 2026 Legislature SENATE BILL 223 against an individual on the basis of sexual orientation, gender identity, or gender expression. 13. The bill expressly prohibits a school board from discriminating against a student-led organization because the organization[s mission is related to sexual orientation, gender identity, or gender expression. For further information see the state and local fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| SJR23 | Proclaiming the week of April 28 to May 2, 2025, as School Nutrition Professionals Appreciation Week. | Relating to: proclaiming the week of April 28 to May 2, 2025, as School Nutrition Professionals Appreciation Week. | Signed/Enacted/Adopted |
| AJR19 | Honoring April 22, 2025, as the 55th anniversary of Earth Day. | Relating to: honoring April 22, 2025, as the 55th anniversary of Earth Day. | Crossed Over |
| AJR20 | Proclaiming the week of April 28 to May 2, 2025, as School Nutrition Professionals Appreciation Week. | Relating to: proclaiming the week of April 28 to May 2, 2025, as School Nutrition Professionals Appreciation Week. | In Committee |
| AJR27 | Condemning the pardons and sentence commutations of individuals involved in the violent attack on law enforcement officers at the U.S. Capitol on January 6, 2021. | Relating to: condemning the pardons and sentence commutations of individuals involved in the violent attack on law enforcement officers at the U.S. Capitol on January 6, 2021. | In Committee |
| AJR30 | Congratulating the University of Wisconsin–Madison women’s hockey team on winning the 2025 NCAA Division I Women’s Hockey National Championship. | Relating to: congratulating the University of Wisconsin]Madison women[s hockey team on winning the 2025 NCAA Division I Women[s Hockey National Championship. | In Committee |
| AJR31 | Proclaiming March 31, 2025, as Wisconsin’s Transgender Day of Visibility. | Relating to: proclaiming March 31, 2025, as Wisconsin[s Transgender Day of Visibility. | In Committee |
| AB227 | Inducements to sign or refrain from signing nomination papers, recall petitions, and certain other petitions. | Current law prohibits certain kinds of election bribery, including offering, giving, lending, or providing money or anything of value to an elector or other person to induce the elector to vote or refrain from voting. Under current law, Xanything of valueY includes an object having utility independent of a political message it contains, the value of which exceeds $1. Election bribery is a Class I felony, the penalty for which is a fine not to exceed $10,000 or imprisonment not to exceed three years and six months, or both. This bill prohibits as election bribery such inducement of an elector to sign or refrain from signing a petition supporting or opposing a candidate, referendum, or proposition about political or social issues, state law, or proposed or potential legislation, if the petition is related to an election or referendum or is circulated during an election period, as defined in the bill. Additionally, the bill prohibits as election bribery such inducement of an elector to sign or refrain from signing nomination papers or a recall petition. Finally, the bill defines Xanything of valueY for purposes of a violation of the bill[s provisions to include an object having utility independent of a political message it contains, if the object[s value exceeds $5, rather than 1$. | In Committee |
| AB147 | The right to repair agricultural equipment, and providing a penalty. (FE) | This bill requires agricultural equipment manufacturers to upon request make available to agricultural equipment owners and independent service providers any documentation, data, embedded software, firmware, parts, or tools that are intended for use with agricultural equipment, at certain fair costs and fair terms as articulated in the bill. XEquipmentY is defined in the bill to include equipment or parts that are designed primarily for use in the operation of a farm or in farm-related activities, including any combine, tractor, sprayer, implement, or attachment used in planting, cultivating, irrigating, harvesting, or ranching, but not including vehicles or self-propelled machines designed primarily for the transportation of persons or property on a street or highway, aircraft, snowmobiles, personal watercraft or motorboats, or equipment or parts used for irrigation purposes. XDataY is defined in the bill to mean information that a manufacturer gathered, transmitted, or compiled that arose from the operation of an owner[s equipment and for which the associated owner has provided consent and authorization for the manufacturer to share. The bill generally does not require manufacturers to provide documentation, parts, embedded software, firmware, or tools that would require a manufacturer to divulge a trade secret. The bill exempts manufacturers and equipment dealers from liability stemming from an owner[s or independent repair provider[s faulty or otherwise improper repair that causes damage or loss of use of equipment, and exempts manufacturers from liability for an action resulting from a person[s use or reliance upon data that the manufacturer provided to a person. For further information see the state fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| SB148 | The right to repair agricultural equipment, and providing a penalty. (FE) | This bill requires agricultural equipment manufacturers to upon request make available to agricultural equipment owners and independent service providers any documentation, data, embedded software, firmware, parts, or tools that are intended for use with agricultural equipment, at certain fair costs and fair terms as articulated in the bill. XEquipmentY is defined in the bill to include equipment or parts that are designed primarily for use in the operation of a farm or in farm-related activities, including any combine, tractor, sprayer, implement, or attachment used in planting, cultivating, irrigating, harvesting, or ranching, but not including vehicles or self-propelled machines designed primarily for the transportation of persons or property on a street or highway, aircraft, snowmobiles, personal watercraft or motorboats, or equipment or parts used for irrigation purposes. XDataY is defined in the bill to mean information that a manufacturer gathered, transmitted, or compiled that arose from the operation of an owner[s equipment and for which the associated owner has provided consent and authorization for the manufacturer to share. The bill generally does not require manufacturers to provide documentation, parts, embedded software, firmware, or tools that would require a manufacturer to divulge a trade secret. The bill exempts manufacturers and equipment dealers LRB-0923/2 JAM:cdc 2025 - 2026 Legislature SENATE BILL 148 from liability stemming from an owner[s or independent repair provider[s faulty or otherwise improper repair that causes damage or loss of use of equipment, and exempts manufacturers from liability for an action resulting from a person[s use or reliance upon data that the manufacturer provided to a person. For further information see the state fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| SJR31 | Proclaiming March 31, 2025, as Wisconsin’s Transgender Day of Visibility. | Relating to: proclaiming March 31, 2025, as Wisconsin[s Transgender Day of Visibility. | In Committee |
| SB142 | Algorithmic software for residential housing, and providing a penalty. | This bill prohibits the use of algorithmic software in setting rental rates or occupancy levels for residential dwelling units and prohibits persons from selling, licensing, or providing algorithmic software to a residential landlord. XAlgorithmic softwareY is defined in the bill to mean software that uses an algorithm to perform calculations on nonpublic competitor data regarding rent or occupancy levels in this state for the purpose of informing a landlord[s decision regarding residential housing occupancy rates, whether to leave a residential unit vacant, or the amount of rent that a landlord may obtain for a residential unit. The Department of Agriculture, Trade and Consumer Protection, the attorney general, or a district attorney may investigate violations of this bill, and the attorney general or a district attorney may commence an action seeking an injunction or to recover a civil forfeiture of up to $1,000 per violation. In addition, a tenant may file a civil action seeking actual damages incurred as a result of a violation of the bill or $1,000 per violation, whichever is greater, or for injunctive relief, or for a combination of injunctive relief and damages. Under the bill, if a landlord includes a provision in a lease that 1) waives the landlord[s obligation to comply with the prohibition on the use of algorithmic software or 2) discourages or impedes a tenant from filing an action seeking LRB-1569/1 JAM:klm 2025 - 2026 Legislature SENATE BILL 142 injunctive relief or damages stemming from the landlord[s violation of the bill[s prohibitions, then the rental agreement is void and unenforceable. | In Committee |
| AB142 | Algorithmic software for residential housing, and providing a penalty. | This bill prohibits the use of algorithmic software in setting rental rates or occupancy levels for residential dwelling units and prohibits persons from selling, licensing, or providing algorithmic software to a residential landlord. XAlgorithmic softwareY is defined in the bill to mean software that uses an algorithm to perform calculations on nonpublic competitor data regarding rent or occupancy levels in this state for the purpose of informing a landlord[s decision regarding residential housing occupancy rates, whether to leave a residential unit vacant, or the amount of rent that a landlord may obtain for a residential unit. The Department of Agriculture, Trade and Consumer Protection, the attorney general, or a district attorney may investigate violations of this bill, and the attorney general or a district attorney may commence an action seeking an injunction or to recover a civil forfeiture of up to $1,000 per violation. In addition, a tenant may file a civil action seeking actual damages incurred as a result of a violation of the bill or $1,000 per violation, whichever is greater, or for injunctive relief, or for a combination of injunctive relief and damages. Under the bill, if a landlord includes a provision in a lease that 1) waives the landlord[s obligation to comply with the prohibition on the use of algorithmic software or 2) discourages or impedes a tenant from filing an action seeking injunctive relief or damages stemming from the landlord[s violation of the bill[s prohibitions, then the rental agreement is void and unenforceable. | In Committee |
| AB97 | Extension of eligibility under the Medical Assistance program for postpartum women. (FE) | This bill requires the Department of Health Services to seek approval from the federal Department of Health and Human Services to extend until the last day of the month in which the 365th day after the last day of the pregnancy falls Medical Assistance benefits to women who are eligible for those benefits when pregnant. Currently, postpartum women are eligible for Medical Assistance benefits until the last day of the month in which the 60th day after the last day of the pregnancy falls. 2021 Wisconsin Act 58 required DHS to seek approval from the federal Department of Health and Human Services to extend these postpartum Medical Assistance benefits until the last day of the month in which the 90th day after the last day of the pregnancy falls. On June 3, 2022, DHS filed a Section 1115 Demonstration Waiver application with the federal Centers for Medicare & Medicaid Services to extend postpartum coverage for eligible Medical Assistance recipients, as required by 2021 Wisconsin Act 58. The Medical Assistance program is a joint federal and state program that provides health services to individuals who have limited financial resources. For further information see the state fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| AB79 | Prosecuting or adjudicating delinquent a person under the age of 18 for committing an act of prostitution. | Under current law, a person who is under the age of 18 may be prosecuted or adjudicated delinquent for committing an act of prostitution, a Class A misdemeanor. Under this bill, a person who is under the age of 18 may not be prosecuted or adjudicated delinquent for committing an act of prostitution. This bill also eliminates the option under current law in cases where a person under the age of 18 has committed an act of prostitution for a court to enter a consent decree under the Juvenile Justice Code, or a deferred prosecution agreement under the Juvenile Justice Code or adult criminal statutes, if the court determines that a consent decree or deferred prosecution agreement will serve the best interests of the person being prosecuted and will not harm society. | In Committee |
| SB70 | A minor’s authority to consent to health care. | This bill allows a minor who is an unaccompanied youth to consent to, contract for, and receive medically necessary care without a parent[s or guardian[s permission, authority, or consent under certain circumstances. The bill defines Xunaccompanied youthY as the term is defined under federal law, which is a homeless youth not in the physical custody of a parent or guardian. The bill defines Xmedically necessary careY as a medical service that is required to prevent, identify, or treat a recipient[s illness, injury, or disability and that meets a set of standards specified in the bill. Under the bill, in order to consent to health care, such a minor must be at least 14 years of age and must not be under the supervision of a county department of human services or social services, a licensed child welfare agency, the Department of Children and Families, or the Department of Corrections. Also under the bill, one of the following must confirm in writing that the minor is an unaccompanied youth: a local educational agency liaison for homeless children and youths designated under federal law, a school social worker or counselor, an employee who conducts intake at a shelter facility or transitional living program where the minor has been admitted as an unaccompanied youth under current law, or the director, or his or her designee, of a governmental or nonprofit entity that receives public or LRB-0487/1 EHS:cdc 2025 - 2026 Legislature SENATE BILL 70 private funding to provide services to individuals who are homeless or to unaccompanied youth. Under the bill, a professional who provides medically necessary care to a minor based on the minor[s consent given in conformity with the bill may not be held liable in a civil or criminal action for providing those services without having obtained permission from the minor[s parent or guardian. | In Committee |
| AB49 | A minor’s authority to consent to health care. | This bill allows a minor who is an unaccompanied youth to consent to, contract for, and receive medically necessary care without a parent[s or guardian[s permission, authority, or consent under certain circumstances. The bill defines Xunaccompanied youthY as the term is defined under federal law, which is a homeless youth not in the physical custody of a parent or guardian. The bill defines Xmedically necessary careY as a medical service that is required to prevent, identify, or treat a recipient[s illness, injury, or disability and that meets a set of standards specified in the bill. Under the bill, in order to consent to health care, such a minor must be at least 14 years of age and must not be under the supervision of a county department of human services or social services, a licensed child welfare agency, the Department of Children and Families, or the Department of Corrections. Also under the bill, one of the following must confirm in writing that the minor is an unaccompanied youth: a local educational agency liaison for homeless children and youths designated under federal law, a school social worker or counselor, an employee who conducts intake at a shelter facility or transitional living program where the minor has been admitted as an unaccompanied youth under current law, or the director, or his or her designee, of a governmental or nonprofit entity that receives public or private funding to provide services to individuals who are homeless or to unaccompanied youth. Under the bill, a professional who provides medically necessary care to a minor based on the minor[s consent given in conformity with the bill may not be held liable in a civil or criminal action for providing those services without having obtained permission from the minor[s parent or guardian. | In Committee |
| AJR5 | Proclaiming February 2025 as Black History Month. | Relating to: proclaiming February 2025 as Black History Month. | Signed/Enacted/Adopted |
| SR2 | Proclaiming March 2025 and March 2026 as Women’s History Months. | Relating to: proclaiming March 2025 and March 2026 as Women[s History Months. | In Committee |
| SJR19 | Honoring the life and public service of Representative Jonathan Brostoff. | Relating to: honoring the life and public service of Representative Jonathan Brostoff. | In Committee |
| SB135 | Special observance days in schools. | This bill adds February 18, Vel R. Phillips[s birthday, to the list of special observance days that apply to general school operations. Current law provides a list of 22 special observance days, including Dr. Martin Luther King, Jr. Day; Susan B. Anthony[s birthday; Environmental Awareness Day; Bullying Awareness Day; and Veterans Day. Under current law, a special observance day must be appropriately observed when school is held on that day or, if the day falls on a Saturday or Sunday, on the school day immediately preceding or following the special observance day. | In Committee |
| SJR17 | Honoring April 22, 2025, as the 55th anniversary of Earth Day. | Relating to: honoring April 22, 2025, as the 55th anniversary of Earth Day. | In Committee |
| AB125 | Special observance days in schools. | This bill adds February 18, Vel R. Phillips[s birthday, to the list of special observance days that apply to general school operations. Current law provides a list of 22 special observance days, including Dr. Martin Luther King, Jr. Day; Susan B. Anthony[s birthday; Environmental Awareness Day; Bullying Awareness Day; and Veterans Day. Under current law, a special observance day must be appropriately observed when school is held on that day or, if the day falls on a Saturday or Sunday, on the school day immediately preceding or following the special observance day. | In Committee |
| AB52 | Expanding the homestead income tax credit. (FE) | Under current law, the homestead tax credit is a refundable income tax credit that may be claimed by homeowners and renters. The credit is based on the claimant[s household income and the amount of property taxes or rent constituting property taxes on his or her Wisconsin homestead. Because the credit is refundable, if the credit exceeds the claimant[s income tax liability, he or she receives the excess as a refund check. Under current law, there are three key dollar amounts used when calculating the credit: 1. If household income is $8,060 or less, the credit is 80 percent of the property taxes or rent constituting property taxes. If household income exceeds $8,060, the property taxes or rent constituting property taxes are reduced by 8.785 percent of the household income exceeding $8,060, and the credit is 80 percent of the reduced property taxes or rent constituting property taxes. 2. The credit may not be claimed if household income exceeds $24,680. 3. The maximum property taxes or rent constituting property taxes used to calculate the credit is $1,460. Beginning with claims filed for the 2025 tax year, this bill reduces the percentage used for household income over $8,060 from 8.785 to 5.614 percent and increases the maximum income amount from $24,680 to $35,000. The bill also indexes the $8,060, $35,000, and $1,460 amounts for inflation during future tax years. For further information see the state fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| SB60 | Expanding the homestead income tax credit. (FE) | Under current law, the homestead tax credit is a refundable income tax credit that may be claimed by homeowners and renters. The credit is based on the claimant[s household income and the amount of property taxes or rent constituting property taxes on his or her Wisconsin homestead. Because the credit is refundable, if the credit exceeds the claimant[s income tax liability, he or she receives the excess as a refund check. Under current law, there are three key dollar amounts used when calculating the credit: 1. If household income is $8,060 or less, the credit is 80 percent of the property taxes or rent constituting property taxes. If household income exceeds $8,060, the property taxes or rent constituting property taxes are reduced by 8.785 percent of the household income exceeding $8,060, and the credit is 80 percent of the reduced property taxes or rent constituting property taxes. 2. The credit may not be claimed if household income exceeds $24,680. LRB-2169/1 KP:cdc 2025 - 2026 Legislature SENATE BILL 60 3. The maximum property taxes or rent constituting property taxes used to calculate the credit is $1,460. Beginning with claims filed for the 2025 tax year, this bill reduces the percentage used for household income over $8,060 from 8.785 to 5.614 percent and increases the maximum income amount from $24,680 to $35,000. The bill also indexes the $8,060, $35,000, and $1,460 amounts for inflation during future tax years. For further information see the state fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| SJR15 | Condemning the pardons and sentence commutations of individuals involved in the violent attack on law enforcement officers at the U.S. Capitol on January 6, 2021. | Relating to: condemning the pardons and sentence commutations of individuals involved in the violent attack on law enforcement officers at the U.S. Capitol on January 6, 2021. | In Committee |
| AB48 | Providing state aid to reimburse public and private schools that provide free meals to all pupils for the costs of those meals and making an appropriation. (FE) | This bill provides additional state aid to public and private schools in this state that provide free meals to all pupils. Under current law, the Department of Public Instruction makes payments to school districts, private schools, independent charter schools, tribal schools, the Wisconsin Educational Services Program for the Deaf and Hard of Hearing, and the Wisconsin Center for the Blind and Visually Impaired to partially match the federal contribution under the National School Lunch Program, under which schools provide free or reduced-price lunches to low-income children. Currently, the state share for school lunches is a variable percentage of the amount of the federal basic reimbursement, which is then allocated among eligible schools according to the number of lunches served during the prior school year. Also under current law, DPI provides a per meal reimbursement to school districts, private schools, and tribal schools that provide breakfast to pupils under the federal School Breakfast Program. Currently, the state provides a per meal reimbursement of $0.15 for each breakfast served under the program, but, if there is insufficient funding to pay the full amount, DPI prorates the payments. Under the bill, a school is eligible for additional state reimbursement for lunches and breakfasts served in a school year if the school 1) participates in both the National School Lunch Program and the federal School Breakfast Program for the school year; and 2) for each school day in which school is in session during the school year, provides to any pupil who requests one, at no cost to the pupil, one lunch and one breakfast that meet the federal food, nutritional, and other requirements for meals served under the federal programs. Under the bill, DPI must reimburse an eligible school a per meal amount that is equal to the federal reimbursement rate applicable to the eligible school under the applicable federal program for a meal served to a pupil who satisfies the income eligibility criteria for a free lunch, minus any amount the eligible school receives from the federal government to pay for those meals. In other words, the bill guarantees that an eligible school will receive a total amount in state and federal aid that will reimburse the eligible school an amount equal to the free meal reimbursement rate for each meal the eligible school serves. The additional state reimbursement under the bill is available to school districts, independent charter schools, private schools, tribal schools, residential care centers for children and youth, the Wisconsin Educational Services Program for the Deaf and Hard of Hearing, and the Wisconsin Center for the Blind and Visually Impaired that meet the eligibility requirements. Under the bill, if a school does not meet the eligibility requirements for the additional state reimbursement for a school year, all of the following apply: 1. If the school participates in the National School Lunch Program for the school year, DPI will reimburse the school an amount required to meet the state[s matching obligation under the federal program. 2. If the school participates in the federal School Breakfast Program for the school year, DPI will reimburse the school $0.15 for each breakfast served under the federal program, without proration. For further information see the state and local fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| SB67 | Providing state aid to reimburse public and private schools that provide free meals to all pupils for the costs of those meals and making an appropriation. (FE) | This bill provides additional state aid to public and private schools in this state that provide free meals to all pupils. Under current law, the Department of Public Instruction makes payments to school districts, private schools, independent charter schools, tribal schools, the Wisconsin Educational Services Program for the Deaf and Hard of Hearing, and the Wisconsin Center for the Blind and Visually Impaired to partially match the federal contribution under the National School Lunch Program, under which schools provide free or reduced-price lunches to low-income children. Currently, the state share for school lunches is a variable percentage of the amount of the federal basic LRB-2213/1 KMS:amn 2025 - 2026 Legislature SENATE BILL 67 reimbursement, which is then allocated among eligible schools according to the number of lunches served during the prior school year. Also under current law, DPI provides a per meal reimbursement to school districts, private schools, and tribal schools that provide breakfast to pupils under the federal School Breakfast Program. Currently, the state provides a per meal reimbursement of $0.15 for each breakfast served under the program, but, if there is insufficient funding to pay the full amount, DPI prorates the payments. Under the bill, a school is eligible for additional state reimbursement for lunches and breakfasts served in a school year if the school 1) participates in both the National School Lunch Program and the federal School Breakfast Program for the school year; and 2) for each school day in which school is in session during the school year, provides to any pupil who requests one, at no cost to the pupil, one lunch and one breakfast that meet the federal food, nutritional, and other requirements for meals served under the federal programs. Under the bill, DPI must reimburse an eligible school a per meal amount that is equal to the federal reimbursement rate applicable to the eligible school under the applicable federal program for a meal served to a pupil who satisfies the income eligibility criteria for a free lunch, minus any amount the eligible school receives from the federal government to pay for those meals. In other words, the bill guarantees that an eligible school will receive a total amount in state and federal aid that will reimburse the eligible school an amount equal to the free meal reimbursement rate for each meal the eligible school serves. The additional state reimbursement under the bill is available to school districts, independent charter schools, private schools, tribal schools, residential care centers for children and youth, the Wisconsin Educational Services Program for the Deaf and Hard of Hearing, and the Wisconsin Center for the Blind and Visually Impaired that meet the eligibility requirements. Under the bill, if a school does not meet the eligibility requirements for the additional state reimbursement for a school year, all of the following apply: 1. If the school participates in the National School Lunch Program for the school year, DPI will reimburse the school an amount required to meet the state[s matching obligation under the federal program. 2. If the school participates in the federal School Breakfast Program for the school year, DPI will reimburse the school $0.15 for each breakfast served under the federal program, without proration. For further information see the state and local fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| AB62 | Health care costs omnibus, granting rule-making authority, making an appropriation, and providing a penalty. (FE) | Elimination of cost sharing for prescription drugs under the Medical Assistance program Under current law, certain persons who receive health services under the Medical Assistance program, also known in this state as BadgerCare, are required to contribute a cost-sharing payment to the cost of certain health services. This bill eliminates all cost-sharing payments for prescription drugs under the Medical Assistance program. The Medical Assistance program is a joint state and federal program that provides health services to individuals who have limited financial resources. Cost-sharing cap on insulin The bill prohibits every health insurance policy and governmental self-insured health plan that covers insulin and imposes cost sharing on prescription drugs from imposing cost sharing on insulin in an amount that exceeds $35 for a one-month supply. Current law requires every health insurance policy that provides coverage of expenses incurred for treatment of diabetes to provide coverage for specified expenses and items, including insulin. The required coverage under current law for certain diabetes treatments other than insulin infusion pumps is subject to the same exclusions, limitations, deductibles, and coinsurance provisions of the policy as other covered expenses. The bill[s cost-sharing limitation on insulin supersedes the specification that the exclusions, limitations, deductibles, and coinsurance are the same as for other coverage. Fiduciary and disclosure requirements for pharmacy benefit managers The bill imposes fiduciary and disclosure requirements on pharmacy benefit managers. Pharmacy benefit managers contract with health plans that provide prescription drug benefits to administer those benefits for the plans. They also have contracts with pharmacies and pay the pharmacies for providing drugs to the plan beneficiaries. The bill provides that a pharmacy benefit manager owes a fiduciary duty to a health plan sponsor. The bill also requires that a pharmacy benefit manager annually disclose all of the following information to the plan sponsor: 1. The indirect profit received by the pharmacy benefit manager from owning a pharmacy or service provider. 2. Any payments made to a consultant or broker who works on behalf of the plan sponsor. 3. From the amounts received from drug manufacturers, the amounts retained by the pharmacy benefit manager that are related to the plan sponsor[s claims or bona fide service fees. 4. The amounts received from network pharmacies and the amount retained by the pharmacy benefit manager. Reimbursements for certain 340B program entities The bill prohibits any person from reimbursing certain entities that participate in the federal drug pricing program, known as the 340B program, for a drug subject to an agreement under the program at a rate lower than that paid for the same drug to pharmacies that have a similar prescription volume. The bill also prohibits a person from imposing any fee, charge back, or other adjustment on the basis of the entity[s participation in the 340B program. The entities covered by the prohibitions under the bill are federally qualified health centers, critical access hospitals, and grantees under the federal Ryan White HIV/AIDS program, as well as these entities[ pharmacies and any pharmacy with which any of the entities have contracted to dispense drugs through the 340B program. Drug repository program Under current law, the Department of Health Services must maintain a drug repository program under which any person may donate certain drugs or supplies to be dispensed to and used by eligible individuals, prioritizing uninsured and indigent individuals. The bill allows DHS to partner with out-of-state drug repository programs. The bill also allows out-of-state persons to donate to the drug repository program in Wisconsin and persons in Wisconsin to donate to participating drug repository programs in other states. Further, the bill directs DHS to study and implement a centralized, physical drug repository program. Value-based diabetes medication pilot project The bill directs the Office of the Commissioner of Insurance to develop a pilot project under which a pharmacy benefit manager and pharmaceutical manufacturer are directed to create a value-based, sole-source arrangement to reduce the costs of prescription diabetes medication. The bill allows OCI to promulgate rules to implement the pilot project. Pharmacist continuing education credits for volunteering at free and charitable clinics Under current law, a licensed pharmacist must renew his or her license every two years. An applicant for renewal of a pharmacist license must submit proof that he or she has completed 30 hours of continuing education within the two-year period immediately preceding the date of his or her application. The bill allows pharmacists to meet up to 10 hours of the continuing education requirement for each two-year period by volunteering at a free and charitable clinic approved by the Pharmacy Examining Board. Prescription drug importation program The bill requires the commissioner of insurance, in consultation with persons interested in the sale and pricing of prescription drugs and federal officials and agencies, to design and implement a prescription drug importation program for the benefit of and that generates savings for Wisconsin residents. The bill establishes requirements for the program, including all of the following: 1. The commissioner must designate a state agency to become a licensed wholesale distributor or contract with a licensed wholesale distributor and to seek federal certification and approval to import prescription drugs. 2. The program must comply with certain federal regulations and import from Canadian suppliers only prescription drugs that are not brand-name drugs, have fewer than four competitor drugs in this country, and for which importation creates substantial savings. 3. The commissioner must ensure that prescription drugs imported under the program are not distributed, dispensed, or sold outside of Wisconsin. 4. The program must have an audit procedure to ensure the program complies with certain requirements specified in the bill. Before submitting the proposed program to the federal government for certification, the commissioner must submit the proposed program to the Joint Committee on Finance for its approval. Pharmacy benefits tool grants The bill directs OCI to award grants in an amount of up to $500,000 in each fiscal year to health care providers to develop and implement a patient pharmacy benefits tool that would allow prescribers to disclose the cost of prescription drugs for patients. The tool must be usable by physicians and other prescribers to determine the cost of prescription drugs for their patients. Any health care provider that receives a grant to develop and implement a patient pharmacy benefits tool is required to contribute matching funds equal to at least 50 percent of the total grant awarded. Prescription drug purchasing entity study The bill requires OCI to conduct a study on the viability of creating or implementing a state prescription drug purchasing entity. Licensure of pharmacy services administrative organizations The bill requires that a pharmacy services administrative organization (PSAO) be licensed by OCI. Under the bill, a PSAO is an entity operating in Wisconsin that does all of the following: 1. Contracts with an independent pharmacy to conduct business on the pharmacy[s behalf with a third-party payer. 2. Provides at least one administrative service to an independent pharmacy and negotiates and enters into a contract with a third-party payer or pharmacy benefit manager on the pharmacy[s behalf. The bill defines Xindependent pharmacyY to mean a licensed pharmacy operating in Wisconsin that is under common ownership with no more than two other pharmacies. XAdministrative serviceY is defined to mean assisting with claims or audits, providing centralized payment, performing certification in a specialized care program, providing compliance support, setting flat fees for generic drugs, assisting with store layout, managing inventory, providing marketing support, providing management and analysis of payment and drug dispensing data, or providing resources for retail cash cards. The bill defines Xthird-party payerY to mean an entity operating in Wisconsin that pays or insures health, medical, or prescription drug expenses on behalf of beneficiaries. The bill uses the current law definition of Xpharmacy benefit manager,Y which is an entity doing business in Wisconsin that contracts to administer or manage prescription drug benefits on behalf of an insurer or other entity that provides prescription drug benefits to Wisconsin residents. To obtain the license required by the bill, a person must apply to OCI and provide the contact information for the applicant and a contact person, evidence of financial responsibility of at least $1,000,000, and any other information required by the commissioner by rule. Under the bill, the license fee is set by the commissioner, and the term of a license is two years. The bill also requires that a PSAO disclose to OCI the extent of any ownership or control by an entity that provides pharmacy services; provides prescription drug or device services; or manufactures, sells, or distributes prescription drugs, biologicals, or medical devices. The PSAO must notify OCI within five days of any material change in its ownership or control related to such an entity. Licensure of pharmaceutical representatives The bill requires a pharmaceutical representative to be licensed by OCI and to display the pharmaceutical representative[s license during each visit with a health care professional. The bill defines Xpharmaceutical representativeY to mean an individual who markets or promotes pharmaceuticals to health care professionals on behalf of a pharmaceutical manufacturer for compensation. The term of a license issued under the bill is one year, and the license is renewable. The application to obtain or renew a license must include the applicant[s contact information, a description of the type of work in which the applicant will engage, the license fee, an attestation that professional education requirements are met, proof that any penalties and other fees are paid, and any other information required by OCI by rule. Under the bill, the license fee is set by the commissioner. The bill requires the pharmaceutical representative to report, within four business days, any change to the information provided on the application or any material change to the pharmaceutical representative[s business operations or other information required to be reported under the bill. The bill requires that a pharmaceutical representative complete a professional education course prior to becoming licensed and to annually complete at least five hours of continuing professional education courses. The coursework must include, at a minimum, training in ethical standards, whistleblower protections, and the laws and rules applicable to pharmaceutical marketing. The bill directs the commissioner to regularly publish a list of courses that fulfill the education requirements. Under the bill, a course provider must disclose any conflict of interest to the commissioner, and the courses may not be provided by the employer of a pharmaceutical representative or be funded by the pharmaceutical industry or a third party funded by the industry. The bill requires that, no later than June 1 of each year, a pharmaceutical representative report to OCI the pharmaceutical representative[s total number of contacts with health care professionals in Wisconsin, the specialties of those health care professionals, the location and duration of each contact, the pharmaceuticals discussed, and the value of any item provided to a health care professional. The bill directs the commissioner to publish the information on OCI[s website without identifying individual health care professionals. The bill requires that a pharmaceutical representative, during each contact with a health care professional, disclose the wholesale acquisition cost of any pharmaceuticals discussed and the names of at least three generic prescription drugs from the same therapeutic class. The bill directs the commissioner to promulgate ethical standards for pharmaceutical representatives. Additionally, the bill prohibits a pharmaceutical representative from engaging in deceptive or misleading marketing of a pharmaceutical product; using a title or designation that could reasonably lead a licensed health care professional, or an employee or representative of such a professional, to believe that the pharmaceutical representative is licensed to practice in a health occupation unless the pharmaceutical representative holds a license to practice in that health occupation; or attending a patient examination without the patient[s consent. An individual who violates any of the requirements under the bill is subject to a forfeiture, and the individual[s license may be suspended or revoked. An individual whose license is revoked must wait at least two years before applying for a new license. Insulin safety net programs The bill requires insulin manufacturers to establish a program under which qualifying Wisconsin residents who are in urgent need of insulin and are uninsured or have limited insurance coverage can be dispensed insulin at a pharmacy. An individual is in urgent need of insulin if the individual needs insulin in order to avoid the likelihood of suffering a significant health consequence and possesses less than a seven-day supply of insulin readily available for use. Under the program, if a qualifying individual in urgent need of insulin provides a pharmacy with a form attesting that the individual meets the program[s eligibility requirements, specified proof of residency, and a valid insulin prescription, the pharmacy must dispense a 30-day supply of insulin to the individual and may charge the individual a copayment of no more than $35. The pharmacy may submit an electronic payment claim for the insulin[s acquisition cost to the manufacturer or agree to receive a replacement of the same insulin in the amount dispensed. The bill also requires that each insulin manufacturer establish a patient assistance program to make insulin available to any qualifying Wisconsin resident who, among other requirements, is uninsured or has limited insurance coverage and whose family income does not exceed 400 percent of the federal poverty line. Under the bill, an individual must apply to participate in a manufacturer[s program. If the manufacturer determines that the individual meets the program[s eligibility requirements, the manufacturer must issue the individual a statement of eligibility, which is valid for 12 months and may be renewed. Under the bill, if an individual with a statement of eligibility and valid insulin prescription requests insulin from a pharmacy, the pharmacy must submit an order to the manufacturer, who must then provide a 90-day supply of insulin at no charge to the individual or pharmacy. The pharmacy may charge the individual a copayment of no more than $50. Under the bill, a manufacturer is not required to issue a statement of eligibility if the individual has prescription drug coverage through an individual or group health plan and the manufacturer determines that the individual[s insulin needs are better addressed through the manufacturer[s copayment assistance program. In such case, the manufacturer must provide the individual with necessary drug coupons to submit to a pharmacy, and the individual may not be required to pay more than a $50 copayment for a 90-day supply of insulin. Under the bill, if the manufacturer determines that an individual is not eligible for the patient assistance program, the individual may file an appeal with OCI. The bill directs OCI to establish procedures for deciding appeals. Under the bill, OCI must issue a decision within 10 days, and that decision is final. The bill requires that insulin manufacturers annually report to OCI certain information, including the number of individuals served and the cost of insulin dispensed under the programs and that OCI annually report to the governor and the legislature on the programs. The bill also directs OCI to conduct public outreach and develop an information sheet about the programs, conduct satisfaction surveys of individuals and pharmacies that participate in the programs, and report to the governor and the legislature on the surveys by July 1, 2028. Additionally, the bill requires that OCI develop a training program for health care navigators to assist individuals in accessing appropriate long-term insulin options and maintain a list of trained navigators. The bill provides that a manufacturer that fails to comply with the bill[s provisions may be assessed a forfeiture of up to noncompliance, which increases to $400,000 per month if the manufacturer continues to be in noncompliance after six months and to $600,000 per month if the manufacturer continues to be in noncompliance after one year. The bill[s requirements do not apply to manufacturers with annual insulin sales revenue in Wisconsin of no more than $2,000,000 or to insulin that costs less than a specified dollar amount. Prescription Drug Affordability Review Board The bill creates a Prescription Drug Affordability Review Board, whose purpose is to protect Wisconsin residents and other stakeholders from the high costs of prescription drugs. The board consists of the commissioner of insurance and the following members, all of whom are appointed by the governor for four-year terms: 1. Two members who represent the pharmaceutical drug industry, at least one of whom is a licensed pharmacist. 2. Two members who represent the health insurance industry. 3. Two members who represent the health care industry, at least one of whom is a licensed practitioner. 4. Two members who represent the interests of the public. The bill requires the board to meet in open session at least four times per year to review prescription drug pricing information. The board must provide at least two weeks[ public notice of each meeting, make the meeting[s materials publicly available at least one week prior to the meeting, and provide the opportunity for public comment. The bill imposes conflict of interest requirements for the board relating to recusal and public disclosure of certain conflicts. The bill directs the board to access and assess drug pricing information, to the extent practicable, by accessing and assessing information from other states, by assessing spending for the drug in Wisconsin, and by accessing other available pricing information. Under the bill, the board must conduct drug cost affordability reviews. The board must identify prescription drugs whose launch wholesale acquisition cost exceeds specified thresholds, prescription drugs whose increase in wholesale acquisition cost exceeds specified thresholds, and other prescription drugs that may create affordability challenges for the health care system in Wisconsin. For each identified prescription drug, the board must determine whether to conduct an affordability review by seeking stakeholder input and considering the average patient cost share for the drug. During an affordability review, the board must determine whether use of the prescription drug that is fully consistent with the labeling approved by the federal Food and Drug Administration or standard medical practice has led or will lead to an affordability challenge for the health care system in Wisconsin. In making this determination, the bill requires the board to consider a variety of factors, which include the following: 1. The drug[s wholesale acquisition cost. 2. The average monetary price concession, discount, or rebate the manufacturer provides, or is expected to provide, for the drug to health plans. 3. The total amount of price concessions, discounts, and rebates the manufacturer provides to each pharmacy benefit manager for the drug. 4. The price at which therapeutic alternatives have been sold and the average monetary concession, discount, or rebate the manufacturer provides, or is expected to provide, to health plan payors and pharmacy benefit managers for therapeutic alternatives. 5. The costs to health plans based on patient access consistent with federal labeled indications and recognized standard medical practice. 6. The impact on patient access resulting from the drug[s cost relative to insurance benefit design. 7. The current or expected dollar value of drug-specific patient access programs that are supported by the manufacturer. 8. The relative financial impacts to health, medical, or social services costs that can be quantified and compared to baseline effects of existing therapeutic alternatives. 9. The average patient copay or other cost sharing for the drug. If the board determines that a prescription drug will lead to an affordability challenge, the bill directs the board to establish an upper payment limit for that drug that applies to all purchases and payor reimbursements of the drug dispensed or administered to individuals in Wisconsin. In establishing the upper payment limit, the board must consider the cost of administering the drug, the cost of delivering it to consumers, and other relevant administrative costs. For certain drugs, the board must solicit information from the manufacturer regarding the price increase and, if the board determines that the price increase is not a result of the need for increased manufacturing capacity or other effort to improve patient access during a public health emergency, the board must establish an upper payment limit equal to the drug[s cost prior to the price increase. Further, this bill provides $500,000 in program revenue in fiscal year 2026]27 for onetime implementation costs associated with establishing an Office of Prescription Drug Affordability in OCI. The bill provides that the Office of Prescription Drug Affordability is responsible for prescription drug affordability programming within OCI and for overseeing the operations of the Prescription Drug Affordability Review Board. Additionally, the bill authorizes and funds for fiscal year 2026]27 16.0 positions for the Office of Prescription Drug Affordability. Finally, the bill credits to the appropriation account for OCI[s general program operations all moneys received from the regulation of pharmacy benefit managers, pharmacy benefit management brokers, pharmacy benefit management consultants, pharmacy services administrative organizations, and pharmaceutical sales representatives. This proposal may contain a health insurance mandate requiring a social and financial impact report under s. 601.423, stats. For further information see the state fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| SB50 | Health care costs omnibus, granting rule-making authority, making an appropriation, and providing a penalty. (FE) | Elimination of cost sharing for prescription drugs under the Medical Assistance program Under current law, certain persons who receive health services under the Medical Assistance program, also known in this state as BadgerCare, are required to contribute a cost-sharing payment to the cost of certain health services. This bill eliminates all cost-sharing payments for prescription drugs under the Medical LRB-1423/1 JPC:all 2025 - 2026 Legislature SENATE BILL 50 Assistance program. The Medical Assistance program is a joint state and federal program that provides health services to individuals who have limited financial resources. Cost-sharing cap on insulin The bill prohibits every health insurance policy and governmental self-insured health plan that covers insulin and imposes cost sharing on prescription drugs from imposing cost sharing on insulin in an amount that exceeds $35 for a one-month supply. Current law requires every health insurance policy that provides coverage of expenses incurred for treatment of diabetes to provide coverage for specified expenses and items, including insulin. The required coverage under current law for certain diabetes treatments other than insulin infusion pumps is subject to the same exclusions, limitations, deductibles, and coinsurance provisions of the policy as other covered expenses. The bill[s cost-sharing limitation on insulin supersedes the specification that the exclusions, limitations, deductibles, and coinsurance are the same as for other coverage. Fiduciary and disclosure requirements for pharmacy benefit managers The bill imposes fiduciary and disclosure requirements on pharmacy benefit managers. Pharmacy benefit managers contract with health plans that provide prescription drug benefits to administer those benefits for the plans. They also have contracts with pharmacies and pay the pharmacies for providing drugs to the plan beneficiaries. The bill provides that a pharmacy benefit manager owes a fiduciary duty to a health plan sponsor. The bill also requires that a pharmacy benefit manager annually disclose all of the following information to the plan sponsor: 1. The indirect profit received by the pharmacy benefit manager from owning a pharmacy or service provider. 2. Any payments made to a consultant or broker who works on behalf of the plan sponsor. 3. From the amounts received from drug manufacturers, the amounts retained by the pharmacy benefit manager that are related to the plan sponsor[s claims or bona fide service fees. 4. The amounts received from network pharmacies and the amount retained by the pharmacy benefit manager. Reimbursements for certain 340B program entities The bill prohibits any person from reimbursing certain entities that participate in the federal drug pricing program, known as the 340B program, for a drug subject to an agreement under the program at a rate lower than that paid for the same drug to pharmacies that have a similar prescription volume. The bill also prohibits a person from imposing any fee, charge back, or other adjustment on the basis of the entity[s participation in the 340B program. The entities covered by the prohibitions under the bill are federally qualified health centers, critical access hospitals, and grantees under the federal Ryan White HIV/AIDS program, as well LRB-1423/1 JPC:all 2025 - 2026 Legislature SENATE BILL 50 as these entities[ pharmacies and any pharmacy with which any of the entities have contracted to dispense drugs through the 340B program. Drug repository program Under current law, the Department of Health Services must maintain a drug repository program under which any person may donate certain drugs or supplies to be dispensed to and used by eligible individuals, prioritizing uninsured and indigent individuals. The bill allows DHS to partner with out-of-state drug repository programs. The bill also allows out-of-state persons to donate to the drug repository program in Wisconsin and persons in Wisconsin to donate to participating drug repository programs in other states. Further, the bill directs DHS to study and implement a centralized, physical drug repository program. Value-based diabetes medication pilot project The bill directs the Office of the Commissioner of Insurance to develop a pilot project under which a pharmacy benefit manager and pharmaceutical manufacturer are directed to create a value-based, sole-source arrangement to reduce the costs of prescription diabetes medication. The bill allows OCI to promulgate rules to implement the pilot project. Pharmacist continuing education credits for volunteering at free and charitable clinics Under current law, a licensed pharmacist must renew his or her license every two years. An applicant for renewal of a pharmacist license must submit proof that he or she has completed 30 hours of continuing education within the two-year period immediately preceding the date of his or her application. The bill allows pharmacists to meet up to 10 hours of the continuing education requirement for each two-year period by volunteering at a free and charitable clinic approved by the Pharmacy Examining Board. Prescription drug importation program The bill requires the commissioner of insurance, in consultation with persons interested in the sale and pricing of prescription drugs and federal officials and agencies, to design and implement a prescription drug importation program for the benefit of and that generates savings for Wisconsin residents. The bill establishes requirements for the program, including all of the following: 1. The commissioner must designate a state agency to become a licensed wholesale distributor or contract with a licensed wholesale distributor and to seek federal certification and approval to import prescription drugs. 2. The program must comply with certain federal regulations and import from Canadian suppliers only prescription drugs that are not brand-name drugs, have fewer than four competitor drugs in this country, and for which importation creates substantial savings. 3. The commissioner must ensure that prescription drugs imported under the program are not distributed, dispensed, or sold outside of Wisconsin. LRB-1423/1 JPC:all 2025 - 2026 Legislature SENATE BILL 50 4. The program must have an audit procedure to ensure the program complies with certain requirements specified in the bill. Before submitting the proposed program to the federal government for certification, the commissioner must submit the proposed program to the Joint Committee on Finance for its approval. Pharmacy benefits tool grants The bill directs OCI to award grants in an amount of up to $500,000 in each fiscal year to health care providers to develop and implement a patient pharmacy benefits tool that would allow prescribers to disclose the cost of prescription drugs for patients. The tool must be usable by physicians and other prescribers to determine the cost of prescription drugs for their patients. Any health care provider that receives a grant to develop and implement a patient pharmacy benefits tool is required to contribute matching funds equal to at least 50 percent of the total grant awarded. Prescription drug purchasing entity study The bill requires OCI to conduct a study on the viability of creating or implementing a state prescription drug purchasing entity. Licensure of pharmacy services administrative organizations The bill requires that a pharmacy services administrative organization (PSAO) be licensed by OCI. Under the bill, a PSAO is an entity operating in Wisconsin that does all of the following: 1. Contracts with an independent pharmacy to conduct business on the pharmacy[s behalf with a third-party payer. 2. Provides at least one administrative service to an independent pharmacy and negotiates and enters into a contract with a third-party payer or pharmacy benefit manager on the pharmacy[s behalf. The bill defines Xindependent pharmacyY to mean a licensed pharmacy operating in Wisconsin that is under common ownership with no more than two other pharmacies. XAdministrative serviceY is defined to mean assisting with claims or audits, providing centralized payment, performing certification in a specialized care program, providing compliance support, setting flat fees for generic drugs, assisting with store layout, managing inventory, providing marketing support, providing management and analysis of payment and drug dispensing data, or providing resources for retail cash cards. The bill defines Xthird-party payerY to mean an entity operating in Wisconsin that pays or insures health, medical, or prescription drug expenses on behalf of beneficiaries. The bill uses the current law definition of Xpharmacy benefit manager,Y which is an entity doing business in Wisconsin that contracts to administer or manage prescription drug benefits on behalf of an insurer or other entity that provides prescription drug benefits to Wisconsin residents. To obtain the license required by the bill, a person must apply to OCI and provide the contact information for the applicant and a contact person, evidence of LRB-1423/1 JPC:all 2025 - 2026 Legislature SENATE BILL 50 financial responsibility of at least $1,000,000, and any other information required by the commissioner by rule. Under the bill, the license fee is set by the commissioner, and the term of a license is two years. The bill also requires that a PSAO disclose to OCI the extent of any ownership or control by an entity that provides pharmacy services; provides prescription drug or device services; or manufactures, sells, or distributes prescription drugs, biologicals, or medical devices. The PSAO must notify OCI within five days of any material change in its ownership or control related to such an entity. Licensure of pharmaceutical representatives The bill requires a pharmaceutical representative to be licensed by OCI and to display the pharmaceutical representative[s license during each visit with a health care professional. The bill defines Xpharmaceutical representativeY to mean an individual who markets or promotes pharmaceuticals to health care professionals on behalf of a pharmaceutical manufacturer for compensation. The term of a license issued under the bill is one year, and the license is renewable. The application to obtain or renew a license must include the applicant[s contact information, a description of the type of work in which the applicant will engage, the license fee, an attestation that professional education requirements are met, proof that any penalties and other fees are paid, and any other information required by OCI by rule. Under the bill, the license fee is set by the commissioner. The bill requires the pharmaceutical representative to report, within four business days, any change to the information provided on the application or any material change to the pharmaceutical representative[s business operations or other information required to be reported under the bill. The bill requires that a pharmaceutical representative complete a professional education course prior to becoming licensed and to annually complete at least five hours of continuing professional education courses. The coursework must include, at a minimum, training in ethical standards, whistleblower protections, and the laws and rules applicable to pharmaceutical marketing. The bill directs the commissioner to regularly publish a list of courses that fulfill the education requirements. Under the bill, a course provider must disclose any conflict of interest to the commissioner, and the courses may not be provided by the employer of a pharmaceutical representative or be funded by the pharmaceutical industry or a third party funded by the industry. The bill requires that, no later than June 1 of each year, a pharmaceutical representative report to OCI the pharmaceutical representative[s total number of contacts with health care professionals in Wisconsin, the specialties of those health care professionals, the location and duration of each contact, the pharmaceuticals discussed, and the value of any item provided to a health care professional. The bill directs the commissioner to publish the information on OCI[s website without identifying individual health care professionals. The bill requires that a pharmaceutical representative, during each contact with a health care professional, disclose the wholesale acquisition cost of any LRB-1423/1 JPC:all 2025 - 2026 Legislature SENATE BILL 50 pharmaceuticals discussed and the names of at least three generic prescription drugs from the same therapeutic class. The bill directs the commissioner to promulgate ethical standards for pharmaceutical representatives. Additionally, the bill prohibits a pharmaceutical representative from engaging in deceptive or misleading marketing of a pharmaceutical product; using a title or designation that could reasonably lead a licensed health care professional, or an employee or representative of such a professional, to believe that the pharmaceutical representative is licensed to practice in a health occupation unless the pharmaceutical representative holds a license to practice in that health occupation; or attending a patient examination without the patient[s consent. An individual who violates any of the requirements under the bill is subject to a forfeiture, and the individual[s license may be suspended or revoked. An individual whose license is revoked must wait at least two years before applying for a new license. Insulin safety net programs The bill requires insulin manufacturers to establish a program under which qualifying Wisconsin residents who are in urgent need of insulin and are uninsured or have limited insurance coverage can be dispensed insulin at a pharmacy. An individual is in urgent need of insulin if the individual needs insulin in order to avoid the likelihood of suffering a significant health consequence and possesses less than a seven-day supply of insulin readily available for use. Under the program, if a qualifying individual in urgent need of insulin provides a pharmacy with a form attesting that the individual meets the program[s eligibility requirements, specified proof of residency, and a valid insulin prescription, the pharmacy must dispense a 30-day supply of insulin to the individual and may charge the individual a copayment of no more than $35. The pharmacy may submit an electronic payment claim for the insulin[s acquisition cost to the manufacturer or agree to receive a replacement of the same insulin in the amount dispensed. The bill also requires that each insulin manufacturer establish a patient assistance program to make insulin available to any qualifying Wisconsin resident who, among other requirements, is uninsured or has limited insurance coverage and whose family income does not exceed 400 percent of the federal poverty line. Under the bill, an individual must apply to participate in a manufacturer[s program. If the manufacturer determines that the individual meets the program[s eligibility requirements, the manufacturer must issue the individual a statement of eligibility, which is valid for 12 months and may be renewed. Under the bill, if an individual with a statement of eligibility and valid insulin prescription requests insulin from a pharmacy, the pharmacy must submit an order to the manufacturer, who must then provide a 90-day supply of insulin at no charge to the individual or pharmacy. The pharmacy may charge the individual a copayment of no more than $50. Under the bill, a manufacturer is not required to issue a statement of eligibility if the individual has prescription drug coverage through an individual or LRB-1423/1 JPC:all 2025 - 2026 Legislature SENATE BILL 50 group health plan and the manufacturer determines that the individual[s insulin needs are better addressed through the manufacturer[s copayment assistance program. In such case, the manufacturer must provide the individual with necessary drug coupons to submit to a pharmacy, and the individual may not be required to pay more than a $50 copayment for a 90-day supply of insulin. Under the bill, if the manufacturer determines that an individual is not eligible for the patient assistance program, the individual may file an appeal with OCI. The bill directs OCI to establish procedures for deciding appeals. Under the bill, OCI must issue a decision within 10 days, and that decision is final. The bill requires that insulin manufacturers annually report to OCI certain information, including the number of individuals served and the cost of insulin dispensed under the programs and that OCI annually report to the governor and the legislature on the programs. The bill also directs OCI to conduct public outreach and develop an information sheet about the programs, conduct satisfaction surveys of individuals and pharmacies that participate in the programs, and report to the governor and the legislature on the surveys by July 1, 2028. Additionally, the bill requires that OCI develop a training program for health care navigators to assist individuals in accessing appropriate long-term insulin options and maintain a list of trained navigators. The bill provides that a manufacturer that fails to comply with the bill[s provisions may be assessed a forfeiture of up to noncompliance, which increases to $400,000 per month if the manufacturer continues to be in noncompliance after six months and to $600,000 per month if the manufacturer continues to be in noncompliance after one year. The bill[s requirements do not apply to manufacturers with annual insulin sales revenue in Wisconsin of no more than $2,000,000 or to insulin that costs less than a specified dollar amount. Prescription Drug Affordability Review Board The bill creates a Prescription Drug Affordability Review Board, whose purpose is to protect Wisconsin residents and other stakeholders from the high costs of prescription drugs. The board consists of the commissioner of insurance and the following members, all of whom are appointed by the governor for four-year terms: 1. Two members who represent the pharmaceutical drug industry, at least one of whom is a licensed pharmacist. 2. Two members who represent the health insurance industry. 3. Two members who represent the health care industry, at least one of whom is a licensed practitioner. 4. Two members who represent the interests of the public. The bill requires the board to meet in open session at least four times per year to review prescription drug pricing information. The board must provide at least two weeks[ public notice of each meeting, make the meeting[s materials publicly available at least one week prior to the meeting, and provide the opportunity for LRB-1423/1 JPC:all $200,000 per month of 2025 - 2026 Legislature SENATE BILL 50 public comment. The bill imposes conflict of interest requirements for the board relating to recusal and public disclosure of certain conflicts. The bill directs the board to access and assess drug pricing information, to the extent practicable, by accessing and assessing information from other states, by assessing spending for the drug in Wisconsin, and by accessing other available pricing information. Under the bill, the board must conduct drug cost affordability reviews. The board must identify prescription drugs whose launch wholesale acquisition cost exceeds specified thresholds, prescription drugs whose increase in wholesale acquisition cost exceeds specified thresholds, and other prescription drugs that may create affordability challenges for the health care system in Wisconsin. For each identified prescription drug, the board must determine whether to conduct an affordability review by seeking stakeholder input and considering the average patient cost share for the drug. During an affordability review, the board must determine whether use of the prescription drug that is fully consistent with the labeling approved by the federal Food and Drug Administration or standard medical practice has led or will lead to an affordability challenge for the health care system in Wisconsin. In making this determination, the bill requires the board to consider a variety of factors, which include the following: 1. The drug[s wholesale acquisition cost. 2. The average monetary price concession, discount, or rebate the manufacturer provides, or is expected to provide, for the drug to health plans. 3. The total amount of price concessions, discounts, and rebates the manufacturer provides to each pharmacy benefit manager for the drug. 4. The price at which therapeutic alternatives have been sold and the average monetary concession, discount, or rebate the manufacturer provides, or is expected to provide, to health plan payors and pharmacy benefit managers for therapeutic alternatives. 5. The costs to health plans based on patient access consistent with federal labeled indications and recognized standard medical practice. 6. The impact on patient access resulting from the drug[s cost relative to insurance benefit design. 7. The current or expected dollar value of drug-specific patient access programs that are supported by the manufacturer. 8. The relative financial impacts to health, medical, or social services costs that can be quantified and compared to baseline effects of existing therapeutic alternatives. 9. The average patient copay or other cost sharing for the drug. If the board determines that a prescription drug will lead to an affordability challenge, the bill directs the board to establish an upper payment limit for that drug that applies to all purchases and payor reimbursements of the drug dispensed or administered to individuals in Wisconsin. In establishing the upper payment limit, the board must consider the cost of administering the drug, the cost of delivering it to consumers, and other relevant administrative costs. For certain LRB-1423/1 JPC:all 2025 - 2026 Legislature SENATE BILL 50 drugs, the board must solicit information from the manufacturer regarding the price increase and, if the board determines that the price increase is not a result of the need for increased manufacturing capacity or other effort to improve patient access during a public health emergency, the board must establish an upper payment limit equal to the drug[s cost prior to the price increase. Further, this bill provides $500,000 in program revenue in fiscal year 2026]27 for onetime implementation costs associated with establishing an Office of Prescription Drug Affordability in OCI. The bill provides that the Office of Prescription Drug Affordability is responsible for prescription drug affordability programming within OCI and for overseeing the operations of the Prescription Drug Affordability Review Board. Additionally, the bill authorizes and funds for fiscal year 2026]27 16.0 positions for the Office of Prescription Drug Affordability. Finally, the bill credits to the appropriation account for OCI[s general program operations all moneys received from the regulation of pharmacy benefit managers, pharmacy benefit management brokers, pharmacy benefit management consultants, pharmacy services administrative organizations, and pharmaceutical sales representatives. This proposal may contain a health insurance mandate requiring a social and financial impact report under s. 601.423, stats. For further information see the state fiscal estimate, which will be printed as an appendix to this bill. | In Committee |
| SJR10 | Proclaiming February 2025 as Black History Month. | Relating to: proclaiming February 2025 as Black History Month. | In Committee |
| AJR3 | Proclaiming January 2025 as Human Trafficking Awareness and Prevention Month in the state of Wisconsin. | Relating to: proclaiming January 2025 as Human Trafficking Awareness and Prevention Month in the state of Wisconsin. | In Committee |
| SJR3 | Proclaiming January 2025 as Human Trafficking Awareness and Prevention Month in the state of Wisconsin. | Relating to: proclaiming January 2025 as Human Trafficking Awareness and Prevention Month in the state of Wisconsin. | In Committee |
| Bill | Bill Name | Motion | Vote Date | Vote |
|---|---|---|---|---|
| SB33 | Representations depicting nudity and providing a penalty. | Senate: Read a third time and passed | 05/15/2025 | Yea |
| SB56 | The use of federal capitalization grant funds for lead service line replacement. (FE) | Senate: Read a third time and passed | 05/15/2025 | Nay |
| SB56 | The use of federal capitalization grant funds for lead service line replacement. (FE) | Senate: Decision of the Chair stands as the judgment of the Senate | 05/15/2025 | Nay |
| SB56 | The use of federal capitalization grant funds for lead service line replacement. (FE) | Senate: Senate Substitute Amendment 1 rejected | 05/15/2025 | Nay |
| AB73 | Statutory recognition of specialized treatment court and commercial court dockets. | Senate: Read a third time and concurred in | 05/15/2025 | Nay |
| AB73 | Statutory recognition of specialized treatment court and commercial court dockets. | Senate: Decision of the Chair stands as the judgment of the Senate | 05/15/2025 | Nay |
| SB96 | Exempting certain electric vehicle charging stations located at a residence from the electric vehicle charging tax. (FE) | Senate: Read a third time and passed | 05/15/2025 | Yea |
| SB125 | A nuclear power siting study and time limits for taking final action on certain certificate of public convenience and necessity applications. (FE) | Senate: Read a third time and passed | 05/15/2025 | Yea |
| SB125 | A nuclear power siting study and time limits for taking final action on certain certificate of public convenience and necessity applications. (FE) | Senate: Decision of the Chair stands as the judgment of the Senate | 05/15/2025 | Nay |
| SB146 | Prohibiting persons who have been convicted of a violent crime from changing their name and providing a penalty. | Senate: Read a third time and passed | 05/15/2025 | Nay |
| SJR48 | Congratulating Knights of Columbus Council 499 for achieving a century of compassionate commitment to service of the Church, their community, and their fellow man. | Senate: Adopted | 05/15/2025 | Yea |
| SB23 | Extension of eligibility under the Medical Assistance program for postpartum women. (FE) | Senate: Read a third time and passed | 04/22/2025 | Yea |
| SB24 | Limitations on the total value of taxable property that may be included in, and the lifespan of, a tax incremental financing district created in the city of Middleton. (FE) | Senate: Read a third time and passed | 04/22/2025 | Yea |
| SB66 | Registration plate concealment devices and providing a penalty. | Senate: Read a third time and passed | 04/22/2025 | Yea |
| SB66 | Registration plate concealment devices and providing a penalty. | Senate: Senate Amendment 1 rejected | 04/22/2025 | Nay |
| SB76 | Dismissing or amending certain criminal charges and deferred prosecution agreements for certain crimes. | Senate: Read a third time and passed | 04/22/2025 | Nay |
| SR3 | Notifying the assembly and the governor that Cyrus Anderson is elected senate chief clerk of the 2025-2026 senate. | Senate: Adopted | 04/22/2025 | Yea |
| SB5 | Battery or threat to jurors and providing a penalty. | Senate: Read a third time and passed | 03/18/2025 | Yea |
| SB4 | Agreements for direct primary care. | Senate: Read a third time and passed | 03/18/2025 | Nay |
| SB4 | Agreements for direct primary care. | Senate: Senate Amendment 1 rejected | 03/18/2025 | Nay |
| AB1 | Changes to the educational assessment program and the school and school district accountability report. (FE) | Senate: Read a third time and concurred in | 03/18/2025 | Nay |
| SB25 | Court-issued criminal complaints in officer-involved deaths. | Senate: Read a third time and passed | 03/18/2025 | Yea |
| SJR7 | Recognizing that the Wisconsin State Legislature supports nuclear power and fusion energy as clean energy sources that are critical to safely meeting Wisconsin’s growing energy demands and declaring the legislature’s commitment to the continuation and expansion of nuclear power and nuclear technologies, the development of nuclear technologies and fusion energy, and employing the leadership and resources necessary to support the development of and investment in nuclear power, fusion energy, and r | Senate: Adopted | 03/18/2025 | Yea |
| AB96 | Ratification of the agreement negotiated between the Board of Regents of the University of Wisconsin System and the Wisconsin State Building Trades Negotiating Committee, for the 2024-25 fiscal year, covering employees in the building trades crafts collective bargaining unit, and authorizing an expenditure of funds. (FE) | Senate: Read a third time and concurred in | 03/18/2025 | Yea |
| AB94 | Ratification of the agreement negotiated between the State of Wisconsin and the Wisconsin State Building Trades Negotiating Committee, for the 2024-25 fiscal year, covering employees in the building trades crafts collective bargaining unit, and authorizing an expenditure of funds. (FE) | Senate: Read a third time and concurred in | 03/18/2025 | Yea |
| AB95 | Ratification of the agreement negotiated between the University of Wisconsin-Madison and the Wisconsin State Building Trades Negotiating Committee, for the 2024-25 fiscal year, covering employees in the building trades crafts collective bargaining unit, and authorizing an expenditure of funds. (FE) | Senate: Read a third time and concurred in | 03/18/2025 | Yea |
| SJR2 | Requiring photographic identification to vote in any election (second consideration). | Senate: Read a third time and adopted | 01/08/2025 | Nay |
| SR1 | Notifying the assembly and the governor that the 2025-2026 senate is organized. | Senate: Adopted | 01/06/2025 | Nay |
| SJR1 | The session schedule for the 2025-2026 biennial session period. | Senate: Adopted | 01/06/2025 | Nay |
| State | District | Chamber | Party | Status | Start Date | End Date |
|---|---|---|---|---|---|---|
| WI | Wisconsin Senate District 14 | Senate | Democrat | In Office | 01/06/2025 |